4.1

Summary

text

MEGALOBLASTIC ANEMIA: OVERVIEW
Pathogenesis	Result of defective DNA synthesis caused by lack of Cobalamin (B12) or Folate; characterized by maturation defects and ineffective erythropoiesis.
Hallmark Findings	Hypercellular bone marrow, hypersegmented neutrophils, and oval macrocytes.
Differential Diagnosis	Lack of Cobalamin, Folate metabolism problems, Antifolate medications (e.g., Methotrexate), or deficiency refractory to treatment.
Key Medication	Methotrexate is a cDMARD known to notoriously cause low folate; its antidote is Folinic Acid (Leucovorin).

[Megaloblastic Anemia Overview] Bone Marrow is usually hypercellular in megaloblastic anemia, and the resulting anemia is based on ineffective erythropoiesis.
[Megaloblastic Anemia Overview] The classic clinical association for Megaloblastic Anemia includes Vitamin B12 deficiency, hypersegmented neutrophils, liver problems, and folic acid deficiency.
[Antifolate Medications] Methotrexate is a conventional synthetic Disease-Modifying Antirheumatic Drug (cDMARD) used in autoimmune conditions and cancer that often causes folate deficiency.
[Antifolate Medications] Folinic Acid (Leucovorin) is the specific antidote used to reverse the effects of Methotrexate toxicity.

COBALAMIN (VITAMIN B12) CHARACTERISTICS
Chemical Structure	Contains a cobalt atom at the center of a corrin ring.
Metabolic Form 1	Adenosylcobalamin (Ado-B12): Located in mitochondria; required for conversion of methylmalonyl-CoA to succinyl-CoA.
Metabolic Form 2	Methylcobalamin: Located in cytoplasm/plasma; converts homocysteine to methionine (deficiency causes megaloblastic anemia).
Dietary Sources	Synthesized solely by microorganisms; found in foods of animal origin (meat, fish, dairy).
Storage & Loss	Stores (2-3 mg) last 3-4 years; daily losses/requirements are 1-3 ug.

[Cobalamin Metabolism] Adenosylcobalamin (Ado-B12) is the mitochondrial form of B12; a deficiency leads to an increase in methylmalonic acid (MMA).
[Cobalamin Metabolism] Methylcobalamin is the cytoplasmic form of B12 involved in converting homocysteine to methionine; a deficiency leads to elevated homocysteine levels.
[Cobalamin Absorption] Intrinsic Factor (IF) is a glycoprotein produced by gastric parietal cells (gene on chromosome 11q13) required for the active absorption of B12 in the ileum.
[Cobalamin Absorption] Cubilin is the specific receptor in the ileum that mediates the endocytosis of the IF-B12 complex.
[Cobalamin Transport] Transcobalamin II (TC II) is the primary protein responsible for delivering cobalamin to tissues like the bone marrow and placenta.
[Cobalamin Transport] Transcobalamin I (Haptocorrin) binds approximately 2/3 of circulating B12 but does not deliver it to tissues.

COBALAMIN DEFICIENCY CAUSES
Dietary
Gastric (IF Lack)
Intestinal
Drugs

[Gastric Causes] Pernicious Anemia is an autoimmune condition characterized by gastric atrophy, loss of parietal cells, and a severe lack of Intrinsic Factor.
[Gastric Causes] Juvenile Pernicious Anemia presents in older children with gastric atrophy and IF antibodies, often associated with autoimmune endocrinopathies.
[Gastric Causes] Gastrectomy (total or partial) leads to B12 deficiency because the removal of the gastric antrum/body eliminates the parietal cells that produce Intrinsic Factor.
[Ileal Causes] Ileal Resection involving ≥1.2 meters of the terminal ileum results in significant B12 malabsorption as this is the primary site of uptake.
[Intestinal Causes] Intestinal Stagnant Loop Syndrome involves bacterial overgrowth in the small intestine where fecal organisms consume B12, causing deficiency.
[Infectious Causes] Diphyllobothrium latum (fish tapeworm) causes B12 deficiency because the parasite competes with the host to consume the vitamin.
[Metabolic Defects] Nitrous Oxide (N2O) irreversibly oxidizes methylcobalamin to an inactive precursor, inactivating methionine synthase and causing rapid megaloblastic changes.
[Rare Syndromes] Imerslund-Grasbeck Syndrome is a rare autosomal recessive condition characterized by selective B12 malabsorption and proteinuria in infants.

FOLATE (VITAMIN B9) CHARACTERISTICS
Dietary Sources
Storage & Loss
Absorption site
High Demand States

[Folate Deficiency] Dietary Folate deficiency is common in populations with limited access to fresh produce or in infants fed solely on goat's milk.
[Folate Malabsorption] PCFT Mutation causes congenital selective folate malabsorption, leading to megaloblastic anemia and CNS abnormalities like convulsions.
[Folate Requirements] Pregnancy increases the folate requirement to 600 µg/day to support fetal transfer and prevent neural tube defects.
[Folate Utilization] Chronic Hemolytic Anemias (e.g., Sickle Cell Disease) lead to folate deficiency due to increased red cell turnover and folate demand.
[Folate Loss] Long-Term Dialysis patients are at risk for folate deficiency because the vitamin is lost through the dialysis membrane.

HEMATOLOGIC & CLINICAL FINDINGS (MEGALOBLASTIC)
Peripheral Blood
Bone Marrow
B12 Neuro Symptoms
Folate Neuro Symptoms

[Hematology] Hypersegmented Neutrophils (defined as having >5 lobes) are one of the earliest and most specific peripheral blood findings in megaloblastic anemia.
[Hematology] Oval Macrocytes are large, oval-shaped red blood cells that result from impaired DNA synthesis and fewer cell divisions.
[Ineffective Hematopoiesis] Unconjugated Bilirubin and LDH may be elevated in megaloblastic anemia due to the premature death of nucleated red cells in the bone marrow.
[Clinical Presentation] Glossitis (a beefy red tongue) is a classic physical exam finding in severe megaloblastic anemia.
[Neurological Impact] Vitamin B12 Deficiency is uniquely associated with demyelinating neurological damage, unlike pure folate deficiency.
[Treatment Safety] Cobalamin Deficiency must be ruled out before giving large doses of folic acid, as folate can correct the anemia but allow irreversible B12 neuropathy to progress.

DIAGNOSIS OF MEGALOBLASTIC ANEMIA
Serum B12
Serum Folate
Red Cell Folate
MMA
Homocysteine

[Laboratory Diagnosis] Methylmalonic Acid (MMA) is the specific biochemical marker used to differentiate B12 deficiency from folate deficiency.
[Laboratory Diagnosis] Serum Folate may rise in severe B12 deficiency due to a block in the conversion of MTHF to THF (the "folate trap").
[Diagnostic Pitfall] Intrinsic Factor Antibodies in serum can cause false-normal serum cobalamin levels in up to 50% of Pernicious Anemia cases.

HEMOLYTIC ANEMIA: CLINICAL & LAB FEATURES
Clinical Triad
Chronic Signs
Lab Markers
Intravascular HA

[Hemolysis Overview] Jaundice in hemolytic anemia is primarily due to an increase in unconjugated/indirect bilirubin from RBC breakdown.
[Hemolysis Overview] Splenomegaly is a classic finding in hemolytic anemia as the spleen is a major site of extravascular red cell destruction.
[Chronic Hemolysis] Skull Bossing occurs in chronic hemolytic states as the bone marrow expands into the skull to compensate for anemia.
[Chronic Hemolysis] Pigment Gallstones (calcium bilirubinate) are common in chronic hemolytic patients due to high bilirubin turnover.

INHERITED HEMOLYTIC ANEMIAS (MEMBRANE & ENZYME)
Hereditary Spherocytosis
G6PD Deficiency
Pyruvate Kinase Def.
SAO

[Hereditary Spherocytosis] MCHC >34 g/dL on a standard blood count is a strong clinical clue for the diagnosis of Hereditary Spherocytosis.
[Hereditary Spherocytosis] Ankyrin (ANK1) is the most common protein mutation responsible for Hereditary Spherocytosis.
[Hereditary Spherocytosis] Splenectomy is the curative treatment for moderate-to-severe HS, but requires prior vaccination against encapsulated bacteria (S. pneumoniae, H. influenzae, N. meningitidis).
[G6PD Deficiency] G6PD Deficiency provides the reducing agent NADPH required to protect RBCs from oxidative damage (e.g., from naphthalene or sulfonamides).
[Pyruvate Kinase Deficiency] Pyruvate Kinase Deficiency is often better tolerated than other anemias because of an increase in 2,3-BPG (DPG), which shifts the oxygen dissociation curve to the right.

AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) COMPARISON
Warm AIHA
Cold Agglutinin (CAD)
Treatment (Warm)
Treatment (Cold)

[Warm AIHA] IgG Autoantibodies in Warm AIHA coat red cells and lead to their removal by Fc receptor-bearing macrophages, largely in the spleen.
[Cold Agglutinin Disease] IgM Autoantibodies bind to RBCs in peripheral cold areas (fingers/toes) and cause strong complement activation.
[Cold Agglutinin Disease] Rituximab is the treatment of choice for Cold Agglutinin Disease because steroids and splenectomy are generally ineffective.
[AIHA Diagnosis] Direct Coombs Test is positive for IgG +/- C3 in Warm AIHA, but positive mainly for C3 in Cold Agglutinin Disease.

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
Pathogenesis
Protective Proteins
Classic Triad
Gold Standard Test
Treatment

[PNH Triad] Venous Thrombosis is the most common cause of death in PNH, often occurring in unusual sites like the hepatic or cerebral veins.
[PNH Pathophysiology] CD59 deficiency is the primary reason for intravascular hemolysis in PNH because it fails to inhibit the membrane attack complex (MAC).
[PNH Presentation] Hemoglobinuria in PNH often presents as dark or "cola-colored" urine, classically noted in the first morning void.
[PNH Complications] Budd-Chiari Syndrome is a high-yield association with PNH due to portal/hepatic vein thrombosis.

EXAM COMPARISON TABLE: DIFFERENTIATING SIMILAR ENTITIES
1. [B12 vs Folate Stores] Vitamin B12 stores last 3-4 years, while Folate stores last only 3-4 months.
2. [Neuropathy] Neurological symptoms are common in B12 deficiency (peripheral neuropathy, spinal cord degeneration) but absent in folate deficiency.
3. [MMA Specificity] Methylmalonic Acid (MMA) is elevated ONLY in B12 deficiency; Homocysteine is elevated in both B12 and folate deficiency.
4. [Absorption Site] B12 is absorbed in the terminal ileum (requires IF), while Folate is absorbed in the duodenum/jejunum.
5. [Inheritance] Hereditary Spherocytosis is usually Autosomal Dominant, while Pyruvate Kinase Deficiency is Autosomal Recessive.
6. [AIHA Antibody] Warm AIHA involves IgG (the "Warm Great" antibody), while Cold Agglutinin Disease involves IgM (the "Cold Miser" antibody).
7. [AIHA Destruction Site] Warm AIHA destruction happens mainly in the spleen; Cold AIHA destruction happens mainly in the liver via Kupffer cells.
8. [Steroid Response] Prednisone is effective for Warm AIHA but ineffective for Cold Agglutinin Disease.
9. [Spherocytes vs Agglutination] Spherocytes are seen in Warm AIHA and Hereditary Spherocytosis; Agglutination (clumping) is seen in Cold Agglutinin Disease.
10. [Enzyme Pathways] Pyruvate Kinase is part of the glycolytic pathway (Embden-Meyerhof); G6PD is part of the hexose monophosphate shunt.
11. [Neonatal Jaundice] Pyruvate Kinase Deficiency causes persistent neonatal jaundice; G6PD Deficiency causes acute hemolytic episodes triggered by stress.
12. [Haptoglobin] Haptoglobin levels are specifically used to identify intravascular hemolysis (it will be depleted/absent).
13. [Pernicious vs Juvenile PA] Pernicious Anemia features parietal cell antibodies; Juvenile Pernicious Anemia often lacks parietal cell antibodies but has IF antibodies and endocrine issues.
14. [B12 vs Folate Drugs] Metformin is associated with B12 deficiency; Methotrexate is associated with folate deficiency.
15. [Treatment Priority] In megaloblastic anemia, one must treat B12 deficiency first (or simultaneously) with folate to prevent the "masking" of neurological disease.
16. [PNH vs Others] PNH is the only hemolytic anemia discussed that is ACQUIRED via a somatic mutation (PIGA), rather than being inherited or purely autoimmune.
17. [G6PD vs PNH] G6PD acts like an "episode" triggered by beans/drugs; PNH acts like a "chronic clone" causing constant intravascular lysis and risk of clots.
18. [IF Sources] Parietal cells produce Intrinsic Factor; Salivary glands produce Haptocorrin (R-binder) which protects B12 in the stomach.
19. [MMA Caveat] Renal Failure can cause a false elevation of Methylmalonic Acid (MMA) even without B12 deficiency.
20. [Transfusion Goal] In PNH, transfusion is avoided unless hemoglobin is <7 g/dL to minimize iron overload and autoantibody formation.
21. [Folinic vs Folic] Folinic acid (Leucovorin) is already reduced and bypasses DHF reductase; Folic acid requires DHF reductase to be activated.
22. [B12 Transport] Transcobalamin II is the "delivery truck" to tissues; Transcobalamin I is the "warehouse" for storage in the blood.
23. [Coombs Comparison] Direct Coombs tests for antibodies already on the patient's RBCs; a positive result for C3 only is highly suggestive of CAD.
24. [Splenectomy Success] Splenectomy is highly effective for HS and Warm AIHA because the spleen is the primary site of destruction for IgG-coated cells or spherocytes.
25. [SAO Feature] Southeast Asia Ovalocytosis (SAO) is likely a malaria-protective polymorphism and often asymptomatic in heterozygotes.

QA

Count	Question	Answer
		MEGALOBLASTIC ANEMIA: OVERVIEW
1	What is the pathogenesis of Megaloblastic Anemia?	Defective DNA synthesis Caused by lack of Cobalamin (B12) or Folate.
2	Enumerate the hallmark findings (3) of Megaloblastic Anemia.	1) Hypercellular bone marrow 2) Hypersegmented neutrophils 3) Oval macrocytes
3	What is the differential diagnosis for Megaloblastic Anemia? (3)	1) Cobalamin/Folate deficiency 2) Antifolate medications 3) Refractory deficiency
4	Which medication is a conventional synthetic Disease-Modifying Antirheumatic Drug (cDMARD) that causes low folate in Megaloblastic Anemia?	Methotrexate
5	What is the specific antidote for Methotrexate toxicity?	Folinic Acid (Leucovorin)
6	Describe the Bone Marrow and erythropoiesis status in megaloblastic anemia.	Hypercellular; ineffective erythropoiesis
7	What is the classic clinical association (4) for Megaloblastic Anemia?	1) Vitamin B12 deficiency 2) Hypersegmented neutrophils 3) Liver problems 4) Folic acid deficiency
8	In what conditions is Methotrexate commonly used before causing folate deficiency?	Autoimmune conditions and cancer
		COBALAMIN (VITAMIN B12) CHARACTERISTICS
9	Describe the chemical structure of Cobalamin (Vitamin B12).	Cobalt atom; corrin ring
10	What is the mitochondrial form of B12 required for Methylmalonyl-CoA conversion?	Adenosylcobalamin (Ado-B12)
11	Which metabolic form of B12 converts Homocysteine to Methionine in the cytoplasm?	Methylcobalamin
12	What are the primary dietary sources of Cobalamin (Vitamin B12)?	Animal origin (meat, fish, dairy)
13	How long do the body stores of Cobalamin (Vitamin B12) last?	3-4 years
14	What are the daily losses and adult requirements for Cobalamin (Vitamin B12)?	1-3 ug
15	A deficiency in Adenosylcobalamin (Ado-B12) leads to an increase in which metabolite?	Methylmalonic acid (MMA)
16	A deficiency in Methylcobalamin leads to elevated levels of which substance?	Homocysteine
17	What glycoprotein produced by gastric parietal cells is required for Cobalamin Absorption?	Intrinsic Factor (IF)
18	Which ileal receptor mediates the endocytosis of the Intrinsic Factor-B12 complex?	Cubilin
19	Which protein is responsible for delivering Cobalamin to the bone marrow and placenta?	Transcobalamin II (TC II)
20	Which protein binds the majority of circulating Cobalamin but does not deliver it to tissues?	Transcobalamin I (Haptocorrin)
		COBALAMIN DEFICIENCY CAUSES
21	Which dietary group is at the highest risk for Cobalamin Deficiency?	Vegans/Strict vegetarians
22	Enumerate the gastric causes (3) of Cobalamin Deficiency.	1) Pernicious Anemia 2) Gastrectomy 3) Congenital IF deficiency
23	Enumerate the intestinal causes (4) of Cobalamin Deficiency.	1) Stagnant Loop Syndrome 2) Ileal Resection 3) Tropical Sprue 4) Fish tapeworm
24	List the drugs (5) commonly associated with Cobalamin Deficiency.	1) Metformin 2) PPIs 3) Nitrous Oxide 4) Alcohol 5) Colchicine
25	Define Pernicious Anemia.	Autoimmune gastric atrophy; loss of parietal cells.
26	How does Juvenile Pernicious Anemia present in older children?	Gastric atrophy; IF antibodies
27	How does a Gastrectomy lead to B12 deficiency?	Eliminates parietal cells
28	How many meters of Ileal Resection results in significant B12 malabsorption?	≥1.2 meters
29	What occurs in Intestinal Stagnant Loop Syndrome to cause B12 deficiency?	Bacterial overgrowth
30	Which parasite causes Cobalamin Deficiency by competing with the host?	Diphyllobothrium latum
31	How does Nitrous Oxide (N2O) cause rapid megaloblastic changes?	Irreversibly oxidizes methylcobalamin
32	What is Imerslund-Grasbeck Syndrome?	Selective B12 malabsorption; proteinuria
		FOLATE (VITAMIN B9) CHARACTERISTICS
33	What are the primary dietary sources of Folate (Vitamin B9)?	Liver, yeast, spinach, greens, nuts
34	How long do the body stores of Folate (Vitamin B9) last?	3-4 months
35	What is the daily requirement of Folate for a normal adult?	100-200 ug
36	Where is Folate (Vitamin B9) primarily absorbed in the body?	Proximal small intestine (Duodenum/Jejunum)
37	Enumerate the high demand states (4) for Folate.	1) Pregnancy 2) Lactation 3) Prematurity 4) Chronic hemolytic anemias
38	What does a PCFT Mutation cause in infants?	Congenital selective folate malabsorption
39	What is the folate requirement during Pregnancy to prevent neural tube defects?	600 µg/day
40	Why do Chronic Hemolytic Anemias like Sickle Cell Disease cause folate deficiency?	Increased red cell turnover
41	Why are Long-Term Dialysis patients at risk for folate deficiency?	Folate lost via dialysis membrane
		HEMATOLOGIC & CLINICAL FINDINGS (MEGALOBLASTIC)
42	Describe the peripheral blood findings (4) of Megaloblastic Anemia.	1) Oval macrocytes 2) Hypersegmented neutrophils 3) Anisocytosis 4) Poikilocytosis
43	Describe the appearance of Bone Marrow in megaloblastic anemia.	Hypercellular with primitive cells
44	Enumerate the B12-specific Neurological Symptoms (3).	1) Peripheral neuropathy 2) Spinal cord degeneration 3) Dementia
45	What is the classic neonatal complication of Folate Deficiency?	Neural tube defects (spina bifida)
46	What constitutes a Hypersegmented Neutrophil?	Neutrophil with >5 lobes
47	How do Oval Macrocytes result from impaired DNA synthesis?	Fewer cell divisions
48	Which lab markers (2) are elevated due to Ineffective Hematopoiesis in megaloblastic anemia?	LDH; Unconjugated bilirubin
49	What is Glossitis?	Beefy red tongue
50	Which deficiency is uniquely associated with Demyelinating Neurological Damage?	Vitamin B12 Deficiency
51	Why must B12 be ruled out before treating Megaloblastic Anemia with high-dose folate?	To prevent irreversible neuropathy
		DIAGNOSIS OF MEGALOBLASTIC ANEMIA
52	What is the threshold for Serum B12 Deficiency?	<74 pmol/L (100 ng/L)
53	Why might Serum Folate be "raised" in a B12 deficiency?	Methyl-THF trap
54	Which measure of folate is more stable and less affected by recent diet?	Red Cell Folate
55	Comparison of Methylmalonic Acid (MMA) in B12 vs Folate deficiency.	Elevated in B12; Normal in Folate
56	Behavior of Homocysteine in B12 and Folate deficiency.	Elevated in both
57	What is the specific biochemical marker to differentiate B12 vs Folate deficiency?	Methylmalonic Acid (MMA)
58	Define the Folate Trap in the context of B12 deficiency.	Blocked conversion of MTHF to THF
59	How do Intrinsic Factor Antibodies affect serum B12 testing?	False-normal B12 levels
		HEMOLYTIC ANEMIA: CLINICAL & LAB FEATURES
60	Enumerate the clinical triad of Hemolytic Anemia.	1) Jaundice 2) Pallor 3) Splenomegaly
61	Enumerate the chronic signs (2) of Hemolytic Anemia.	1) Skeleton changes 2) Pigment gallstones
62	Enumerate the lab markers (4) for Hemolytic Anemia.	1) Low Hb 2) High Reticulocytes 3) High LDH 4) High Unconjugated Bilirubin
63	What are the hallmark markers (2) for Intravascular Hemolysis?	1) Low/Absent Haptoglobin 2) Hemoglobinuria
64	What causes Jaundice in hemolytic anemia?	Increase in unconjugated bilirubin
65	Why does Splenomegaly occur in hemolytic anemia?	Site of red cell destruction
66	What is the cause of Skull Bossing in chronic hemolytic states?	Bone marrow expansion
67	What is the composition of Pigment Gallstones?	Calcium bilirubinate
		INHERITED HEMOLYTIC ANEMIAS
68	What is the most common inherited membrane defect, and its common mutation?	Hereditary Spherocytosis; ANK1 (Ankyrin)
69	What triggers hemolytic episodes in G6PD Deficiency?	Oxidative stress (Fava beans/drugs)
70	What is the most common glycolytic enzyme deficiency?	Pyruvate Kinase Deficiency
71	Describe Southeast Asia Ovalocytosis (SAO) and its mutation.	Band 3 mutation; malaria protection
72	What MCHC value is a clinical clue for Hereditary Spherocytosis?	>34 g/dL
73	Which protein mutation is most common in Hereditary Spherocytosis?	Ankyrin
74	What is the curative treatment for Hereditary Spherocytosis?	Splenectomy
75	Why is G6PD Deficiency harmful to RBCs?	Global lack of NADPH
76	Why is Pyruvate Kinase Deficiency often better tolerated clinically?	Increase in 2,3-BPG (shifts dissociation curve right)
		AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
77	Differentiate Warm AIHA in terms of antibody type and destruction site.	IgG; Spleen (Extravascular)
78	Differentiate Cold Agglutinin Disease (CAD) in terms of antibody type and destruction site.	IgM; Liver/Intravascular
79	Enumerate the treatments (3) for Warm AIHA.	1) Steroids 2) Rituximab 3) Splenectomy
80	Enumerate the treatments (3) for Cold Agglutinin Disease.	1) Cold avoidance 2) Rituximab 3) Sutimlimab
81	How are red cells removed in Warm AIHA?	Fc receptor-bearing macrophages
82	Where do IgM Autoantibodies bind in Cold Agglutinin Disease?	Peripheral cold areas (fingers/toes)
83	Why is Rituximab preferred over steroids in Cold Agglutinin Disease?	Steroids/Splenectomy are generally ineffective
84	Comparison of Direct Coombs Test result for Warm vs Cold AIHA.	Warm: IgG +/- C3 Cold: C3 only
		PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
85	What somatic mutation causes PNH?	PIGA gene
86	Which anchor proteins (2) are missing in PNH?	CD55; CD59
87	Enumerate the classic triad of PNH.	1) Intravascular hemolysis 2) Pancytopenia 3) Venous thrombosis
88	What is the gold standard test for PNH?	Flow Cytometry
89	What is the primary treatment for PNH?	Eculizumab (C5 inhibitor)
90	What is the most common cause of death in PNH?	Venous Thrombosis
91	What is the role of CD59 in the RBC membrane?	Inhibits the Membrane Attack Complex (MAC)
92	What is the classic presentation of Hemoglobinuria in PNH?	Dark/Cola-colored morning urine
93	Which specific syndrome involves PNH and hepatic vein thrombosis?	Budd-Chiari Syndrome
		EXAM COMPARISON TOPICS
94	Comparison of stores duration: B12 vs Folate.	B12: 3-4 years Folate: 3-4 months
95	Existence of Neuropathy: B12 vs Folate.	B12: Present Folate: Absent
96	Comparison of absorption site: B12 vs Folate.	B12: Terminal Ileum Folate: Duodenum/Jejunum
97	Comparison of inheritance: HS vs Pyruvate Kinase Deficiency.	HS: Autosomal Dominant PKD: Autosomal Recessive
98	Comparison of dominant antibody: Warm AIHA vs Cold Agglutinin.	Warm: IgG Cold: IgM
99	Primary site of destruction: Warm vs Cold AIHA.	Warm: Spleen Cold: Liver (Kupffer cells)
100	Effectiveness of Prednisone (steroids): Warm vs Cold AIHA.	Warm: Effective Cold: Ineffective
101	Smear findings differentiation: Warm AIHA vs CAD.	Warm: Spherocytes Cold: Agglutination
102	Comparison of metabolic pathways: PK vs G6PD.	PK: Glycolytic G6PD: Hexose monophosphate shunt
103	Clinical presentation: PK deficiency vs G6PD deficiency.	PK: Persistent neonatal jaundice G6PD: Acute stress episodes
104	Comparison of Pernicious Anemia vs Juvenile PA antibodies.	PA: Parietal cell antibodies Juvenile: IF antibodies only
105	Drug associations: B12 vs Folate deficiency.	B12: Metformin Folate: Methotrexate
106	Why is PNH unique among the hemolytic anemias discussed?	Only ACQUIRED hemolytic anemia (PIGA mutation)
107	Cellular sources: Intrinsic Factor vs Haptocorrin.	IF: Parietal cells Haptocorrin: Salivary glands
108	Clinical caveat: What can cause a false-positive elevation of Methylmalonic Acid (MMA)?	Renal Failure
109	Transfusion trigger in PNH.	Hb < 7 g/dL
110	Contrast Folinic acid vs Folic acid logic.	Folinic bypasses DHF reductase; Folic requires it
111	Functional roles: Transcobalamin II vs Transcobalamin I.	TC II: Delivery agent TC I: Storage/Warehouse
112	Success of Splenectomy in HS and Warm AIHA.	Highly effective (spleen is the site of RBC destruction)

4.2

Summary

text

ANEMIA AND POLYCYTHEMIA: PHYSIOLOGY AND CLINICAL EVALUATION

Topic Component	Anemia Overview & Physiology
Pathogenesis	Inadequate red cell mass generally results from either decreased RBC production (hypoproliferative) or increased RBC destruction/loss (hemolysis or bleeding).
Primary Regulator	Erythropoietin (EPO) is the primary hormone regulating RBC production, produced mainly by peritubular capillary lining cells in the kidney in response to hypoxia.
Critical Elements	Erythropoiesis requires normal renal EPO production, a functioning erythroid marrow, and adequate substrates for hemoglobin synthesis (primarily iron).
RBC Kinetics	Mature RBCs have a lifespan of 100–120 days, with 0.8–1% of the total mass being replaced daily.
Lab Standards	Hemoglobin (Hgb) concentration is clinically preferred over hematocrit because hematocrit is a calculated value and generally less accurate.

Context: Anemia Definitions. The WHO definition of anemia is a Hemoglobin level of <13 g/dL in men and <12 g/dL in women.
Context: Normal Hemoglobin Ranges. Normal Hemoglobin values for adult males range from 13.5–17.5 g/dL, while for adult females the range is 12–15 g/dL.
Context: Physiology of EPO. Erythropoietin (EPO) prevents the apoptosis of erythroid progenitor cells and promotes their proliferation and maturation.
Context: EPO Regulation. Hypoxia-Inducible Factor (HIF-1α) is the key regulator of EPO; in normoxia, it is degraded by the proteasome, but in hypoxia, it translocates to the nucleus to increase EPO gene expression.
Context: Marrow Response. An increased EPO stimulation can increase RBC production 4–5 times the normal rate within 1–2 weeks, provided iron stores are adequate.
Context: RBC Morphology. A mature RBC is approximately 8 µm in diameter, anucleate, biconcave/discoid in shape, and highly deformable to pass through microcirculation.

COMPENSATORY MECHANISMS TO ANEMIA

Mechanism	Physiological Change	Clinical Correlate
Oxygen Affinity	Decreased O2 Affinity via increased 2,3-DPG.	Right shift in the oxygen-dissociation curve; common in chronic anemia and high altitude.
Metabolism	Pasteur Effect: Upregulation of glycolysis.	Conversion to less efficient anaerobic glycolysis for energy during hypoxia.
Perfusion	Blood Shunting to vital organs.	Vasomotor activity diverts blood from skin, kidneys, and gut to the brain and myocardium.
Hemodynamics	Increased Cardiac Output.	Occurs when Hgb <7 g/dL; results in tachycardia, flow murmurs, and pounding pulses.
Pulmonary	Increased Respiratory Function.	Increased respiratory rate to maximize O2 uptake; presents as exertional dyspnea/orthopnea.

Context: Cardiac Compensation. Increased resting cardiac output in anemia typically does not occur until the hemoglobin concentration falls below 7 g/dL.
Context: Physical Examination. Hemodynamic "flow" murmurs and bruits may be heard over the jugular vein, closed eye, or parietal region of the skull in severe anemia.
Context: Hypermetabolism in Cancer. The Warburg Effect is a characteristic of malignant cells where they utilize excess glucose for conversion to lactate even in the presence of oxygen.
Context: Auditory Symptoms. Tinnitus described as "roaring in the ears" can be a clinical sign of increased cardiac output due to severe anemia.
Context: Ischemic Complications. Angina pectoris may supervene during anemia if the oxygen demand of the myocardium exceeds the supply, especially in patients with existing coronary artery disease.

PRACTICAL LABORATORY APPROACH AND RETICULOCYTE COUNT

Step	Measurement	Significance
1. Confirm Anemia	Hgb and Hct levels.	Determines if the red cell mass is truly decreased below WHO cut-offs.
2. Production vs Loss	Reticulocyte Count.	Distinguishes hypoproliferative (<2%) from hemolytic/bleeding (>2%) states.
3. Size/Morphology	MCV & Peripheral Smear.	Categories: Microcytic (<80), Normocytic (80-100), Macrocytic (>100).
4. Iron Status	Serum Iron, Ferritin, TIBC.	Differentiates IDA, Inflammation, and SID/Thalassemia.

Context: Relative Anemia. Dilutional (Relative) Anemia is characterized by a normal total red cell mass but an increased plasma volume, seen in pregnancy, athletes, and macroglobulinemia.
Context: Reticulocyte Life Span. Reticulocytes are immature RBCs that contain ribosomal RNA and typically circulate for 1 day before maturing; they are identified using supravital dyes.
Context: Corrected Reticulocyte Count. The Absolute Reticulocyte Count formula is: Retic Count % × (Patient Hct / Expected Hct).
Context: Bone Marrow Response. The Reticulocyte Production Index (RPI) is calculated as (Absolute Retic Count / Maturation Time Correction); an RPI <2 indicates inadequate marrow response.
Context: Premature Release. Shift Cells (Polychromasia) are reticulocytes released prematurely from the marrow that stay in circulation longer (2 days instead of 1), which can falsely elevate the retic count.
Context: Expected Response. In severe anemia (Hgb <10 g/dL), the reticulocyte production should ideally increase 2–3 times the normal rate within approximately 10 days.

PERIPHERAL BLOOD SMEAR MORPHOLOGY

Finding	Description	Common Clinical Associations
Target Cells	Bull's-eye appearance (Codocytes).	Thalassemia, Liver disease, Hemoglobinopathies (S and C), IDA.
Burr Cells	Regularly spaced small spiny projections (Echinocytes).	Uremia, Liver disease, Carcinoma of the stomach.
Schistocytes	Helmet/Fragmented cells.	TTP, DIC, Mechanical heart valves, Severe burns.
Spur Cells	Irregularly distributed thorn-like projections (Acanthocytes).	Alcoholic liver disease, Abetalipoproteinemia, Post-splenectomy.
Howell-Jolly Bodies	Small blue nuclear remnants.	Asplenia/Hyposplenia, Megaloblastic anemia.
Stomatocytes	Central slit-like area of pallor (Mouth cells).	Hereditary spherocytosis, Alcoholism, Cirrhosis.

Context: Size Variation. Anisocytosis refers to marked variation in RBC size and correlates with a high Red Cell Distribution Width (RDW).
Context: Shape Variation. Poikilocytosis refers to marked variation in RBC shape, frequently indicating defective maturation or RBC fragmentation.
Context: Megaloblastic Features. Hypersegmented neutrophils on a peripheral smear are a hallmark finding of Vitamin B12 or Folate deficiency.
Context: Thalassemia Diagnosis. According to the lecturer, if a peripheral smear shows Codocytes (Target cells), it is highly likely to be Thalassemia, potentially negating the need for electrophoresis to reach a clinical suspicion.
Context: Clinical Site for Pallor. In dark-skinned patients, pallor and jaundice should be inspected under the tongue near the frenulum as well as the palpebral conjunctiva and palms.

IRON DEFICIENCY AND HYPOPROLIFERATIVE ANEMIA DIAGNOSIS

Parameter	Iron Deficiency (IDA)	Inflammation (AI)	Renal Disease	Thalassemia
Ferritin	<15 µg/L (Low)	30–200 µg/L (Normal/High)	Normal/High	Normal/High
TIBC	>360 µg/dL (High)	<300 µg/dL (Low)	Normal	Normal
Serum Iron	<30 µg/dL (Low)	<50 µg/dL (Low)	Normal	Normal/High
MCV	Microcytic	Normocytic → Microcytic	Normocytic	Microcytic
Morphology	Hypochromic	Normocytic/Normochromic	Normocytic	Target Cells

Context: Total Iron Stores. Serum Ferritin is the most sensitive test for evaluating total iron body stores; levels <15 µg/L indicate depletion of iron stores.
Context: Acute Phase Reactant. Ferritin acts as an acute phase reactant and can increase threefold during inflammation, potentially masking iron deficiency.
Context: Iron Transport. Transferrin Saturation calculates the ratio of serum iron to TIBC; a saturation <20% indicates iron deficiency, while >50% indicates iron overload.
Context: Mechanism of AI. Hepcidin is the central hormone in Anemia of Inflammation (AI) that blocks iron release from macrophages and decreases intestinal absorption, leading to iron-restricted erythropoiesis.
Context: AI Cytokines. TNF and INF-B are inflammatory cytokines that suppress EPO production, essentially causing bone marrow failure in the context of acute or chronic inflammation.
Context: Anemia of CKD. Anemia of Chronic Kidney Disease is typically normocytic and normochromic, caused primarily by decreased EPO production proportional to the severity of renal failure.
Context: Hypometabolic States. Anemia in Hypometabolic States (e.g., hypothyroidism or protein starvation) results from reduced oxygen demand leading to decreased EPO release.

HEMOGLOBIN DISORDERS AND TRANSFUSION

Context: Thalassemia in the Philippines. Thalassemias are common in the Philippines and present with microcytic, hypochromic anemia despite normal iron stores; they should not be treated with iron.
Context: Sickle Cell Disease. Sickle Hemoglobinopathies are uncommon in the Philippines but manifest with pain, splenic infarction, and increased risk for stroke and CKD.
Context: General Transfusion Cut-off. The generally accepted hemoglobin threshold for transfusion is <7 g/dL, as levels below this result in tissue hypoxia.
Context: Transfusion in Comorbidity. Transfusion should be considered for Hgb levels between 7–8 g/dL in patients with cardiovascular instability or between 8–10 g/dL in patients with an active MI.
Context: Active Bleeding. In cases of active bleeding, transfusion may be required even if the current hemoglobin level appears normal at that moment.

DIFFERENTIATION AND COMPARSION (THE CONFUSION FIXER)

IDA vs. AI: In Iron Deficiency Anemia (IDA), Ferritin is low and TIBC is high; in Anemia of Inflammation (AI), Ferritin is normal or high and TIBC is low.
Absolute vs. Relative Anemia: Absolute anemia involves a true decrease in red cell mass; Relative anemia involves a normal red cell mass diluted by increased plasma volume (e.g., pregnancy).
Burr Cells vs. Spur Cells: Burr cells (Echinocytes) have regular, small projections and are seen in Uremia; Spur cells (Acanthocytes) have irregular, thorn-like projections and are seen in Liver Disease.
MCV Categories: Microcytic is MCV <80 fL; Normocytic is 80–100 fL; Macrocytic is >100 fL.
Anisocytosis vs. Poikilocytosis: Anisocytosis is variation in size (measured by RDW); Poikilocytosis is variation in shape.
RPI interpretation: An RPI &lt2 suggests a hypoproliferative cause (production problem); an RPI >2–3 suggests hemolysis or acute blood loss (destruction/loss problem).
Megaloblastic vs. Non-megaloblastic Macrocytosis: Megaloblastic macrocytosis features hypersegmented neutrophils (B12/Folate deficiency); Non-megaloblastic macrocytosis does not (Alcohol/Liver disease).
Pasteur vs. Warburg Effect: The Pasteur effect is a normal response to hypoxia (anaerobic glycolysis), while the Warburg effect is malignant glycolysis occurring even with oxygen present.
Alpha vs. Beta Thalassemia Electrophoresis: Beta-thalassemia shows an abnormal pattern on hemoglobin electrophoresis; Alpha-thalassemia often shows a normal electrophoresis pattern.
Serum Iron vs. Ferritin: Serum Iron measures circulating iron; Serum Ferritin is the best indicator of total body iron stores.
Howell-Jolly vs. Pappenheimer Bodies: Howell-Jolly bodies are DNA remnants (Blue, Wright stain) seen in asplenia; they are distinct from iron-containing inclusions.
Iron supplementation: Ferrous sulfate usually contains 60 mg elemental iron, while Sangobion contains 100-140 mg; iron can cause constipation, so sorbitol is sometimes added.
Target Cells (Codocytes) Differential: While seen in Thalassemia, Target Cells can also appear in liver disease and severe iron deficiency.
High RDW: A high RDW implies a mixed population of cells (early deficiency states like IDA or B12 deficiency), whereas a normal RDW with low MCV might suggest Thalassemia.
Transfusion Thresholds: Most stable patients use a 7 g/dL cut-off, but symptomatic CAD or MI patients require a higher threshold of 8-10 g/dL.
Hypoproliferative causes: Anemia of CKD is primarily due to EPO deficiency; Anemia of AI is primarily iron sequestration due to Hepcidin.
Vitamin B12 vs Folate: Both cause megaloblastic anemia, but B12 deficiency is often associated with lower serum B12 levels (normal 200-900 ng/L) and unique neurologic symptoms not mentioned in this text but standard in Harrison's.
Hemoglobin vs Hematocrit Accuracy: Hemoglobin is directly measured; Hematocrit can be misleading because it is affected by plasma volume and is a calculated value.
WHO Anemia in Pregnancy: Hemoglobin levels may naturally drop to 11-12 g/dL due to the dilution effect of increased plasma volume.
Stomatocytosis vs. Spherocytosis: Stomatocytes have a "mouth" slit; Spherocytes are small, dense, and lack central pallor. Both are seen in hereditary membrane defects.

QA

ANEMIA AND POLYCYTHEMIA: PHYSIOLOGY AND CLINICAL EVALUATION

Count	Q	A
1	What two general processes result in an inadequate red cell mass?	Decreased production (hypoproliferative) Increased destruction/loss
2	What is the primary hormone regulating RBC production?	Erythropoietin (EPO)
3	Where is Erythropoietin (EPO) mainly produced?	Peritubular capillary lining cells (Kidney)
4	What triggers the production of Erythropoietin (EPO) in the kidney?	Hypoxia
5	Enumerate the three critical elements required for Erythropoiesis.	1) Normal renal EPO 2) Functioning erythroid marrow 3) Iron (hemoglobin substrates)
6	What is the normal lifespan of Mature RBCs?	100–120 days
7	What percentage of the total RBC mass is replaced daily?	0.8–1%
8	Why is Hemoglobin (Hgb) clinically preferred over hematocrit?	Hematocrit is calculated and less accurate.
9	What is the WHO definition of anemia for men?	Hemoglobin <13 g/dL
10	What is the WHO definition of anemia for women?	Hemoglobin <12 g/dL
11	What are the Normal Hemoglobin values for adult males?	13.5–17.5 g/dL
12	What are the Normal Hemoglobin values for adult females?	12–15 g/dL
13	What is the cellular function of Erythropoietin (EPO) regarding progenitor cells?	Prevents apoptosis; promotes proliferation/maturation.
14	What is the key regulator of EPO that is degraded in normoxia?	Hypoxia-Inducible Factor (HIF-1α)
15	Under hypoxia, where does HIF-1α translocate to increase EPO gene expression?	Nucleus
16	How many times can increased EPO stimulation increase RBC production?	4–5 times normal rate
17	How long does it take for the marrow response to maximize after EPO stimulation?	1–2 weeks
18	Describe the physical characteristics (3) of a mature RBC.	8 µm diameter, anucleate, biconcave/discoid.

COMPENSATORY MECHANISMS TO ANEMIA

Count	Q	A
19	How is Oxygen Affinity modified as a compensatory mechanism in chronic anemia?	Decreased via increased 2,3-DPG.
20	A right shift in the oxygen-dissociation curve is a compensatory change for which conditions (2)?	Chronic anemia; high altitude.
21	Define the Pasteur Effect in the context of hypoxia.	Upregulation of anaerobic glycolysis.
22	Which vital organs receive shunted blood during anemia?	Brain and myocardium.
23	From which sites is blood diverted during Blood Shunting in anemia?	Skin, kidneys, and gut.
24	At what hemoglobin level does Increased Cardiac Output typically occur?	Hgb <7 g/dL
25	What are the clinical signs (3) of hemodynamic compensation in severe anemia?	Tachycardia, flow murmurs, pounding pulses.
26	How does Increased Respiratory Function present clinically in anemic patients?	Exertional dyspnea or orthopnea.
27	Where can Hemodynamic "flow" murmurs and bruits be heard during physical exam (3)?	Jugular vein, closed eye, parietal skull.
28	Define the Warburg Effect in malignant cells.	Glucose conversion to lactate despite oxygen.
29	What auditory symptom indicates increased cardiac output in severe anemia?	Tinnitus ("roaring in the ears").
30	When does Angina pectoris supervene during anemia?	Oxygen demand exceeds supply (coronary disease).

PRACTICAL LABORATORY APPROACH AND RETICULOCYTE COUNT

Count	Q	A
31	What is the first step to confirm anemia?	Check Hgb and Hct levels.
32	What lab value distinguishes production problems from loss/destruction?	Reticulocyte Count
33	What reticulocyte percentage suggests hypoproliferative anemia?	<2%
34	What reticulocyte percentage suggests hemolytic or bleeding states?	>2%
35	Which measurement determines RBC Size/Morphology?	Mean Corpuscular Volume (MCV)
36	Define the MCV range for Microcytic anemia.	<80 fL
37	Define the MCV range for Normocytic anemia.	80–100 fL
38	Define the MCV range for Macrocytic anemia.	>100 fL
39	Which tests (3) evaluate Iron Status?	Serum Iron, Ferritin, TIBC.
40	What characterizes Dilutional (Relative) Anemia?	Normal red mass; increased plasma volume.
41	List three conditions associated with Relative Anemia.	Pregnancy, athletes, macroglobulinemia.
42	What do Reticulocytes contain that allows identification with supravital dyes?	Ribosomal RNA
43	Describe the Absolute Reticulocyte Count formula.	Retic % × (Patient Hct / Expected Hct).
44	How is the Reticulocyte Production Index (RPI) calculated?	Absolute Retic Count / Maturation Correction.
45	What RPI value indicates an inadequate marrow response?	RPI <2
46	Define Shift Cells (Polychromasia).	Reticulocytes released prematurely from marrow.
47	How long do Shift Cells stay in circulation compared to normal reticulocytes?	2 days (vs 1 day).
48	What is the expected response of reticulocyte production in severe anemia?	2–3 times normal increase.
49	How long does it take to see the expected reticulocyte production increase?	Approximately 10 days

PERIPHERAL BLOOD SMEAR MORPHOLOGY

Count	Q	A
50	Describe the appearance of Target Cells (Codocytes).	Bull's-eye appearance.
51	List four clinical associations for Target Cells.	Thalassemia, Liver disease, Hemoglobinopathies, IDA.
52	Describe the morphology of Burr Cells (Echinocytes).	Regularly spaced small spiny projections.
53	List three clinical associations for Burr Cells.	Uremia, Liver disease, stomach carcinoma.
54	What is the appearance of Schistocytes?	Helmet or fragmented cells.
55	List three clinical associations for Schistocytes.	TTP, DIC, Mechanical heart valves.
56	Describe the morphology of Spur Cells (Acanthocytes).	Irregularly distributed thorn-like projections.
57	List three clinical associations for Spur Cells.	Alcoholic liver disease, Abetalipoproteinemia, Post-splenectomy.
58	What are Howell-Jolly Bodies?	Small blue nuclear remnants (DNA).
59	List two clinical associations for Howell-Jolly Bodies.	Asplenia/Hyposplenia, Megaloblastic anemia.
60	Describe Stomatocytes (Mouth cells).	Central slit-like area of pallor.
61	List three clinical associations for Stomatocytes.	Hereditary spherocytosis, Alcoholism, Cirrhosis.
62	Define Anisocytosis and its lab correlate.	RBC size variation; high RDW.
63	Define Poikilocytosis.	Marked variation in RBC shape.
64	What do Hypersegmented neutrophils indicate?	Vitamin B12 or Folate deficiency.
65	Presence of Codocytes on a smear strongly suggests which diagnosis?	Thalassemia
66	Where should pallor be inspected in dark-skinned patients?	Under tongue (frenulum), conjunctiva, palms.

IRON DEFICIENCY AND HYPOPROLIFERATIVE ANEMIA DIAGNOSIS

Count	Q	A
67	What is the Ferritin level in Iron Deficiency Anemia (IDA)?	<15 µg/L (Low)
68	What is the TIBC level in Iron Deficiency Anemia (IDA)?	>360 µg/dL (High)
69	What is the Serum Iron level in IDA?	<30 µg/dL (Low)
70	What is the MCV/Morphology in IDA?	Microcytic and Hypochromic.
71	What is the Ferritin level in Anemia of Inflammation (AI)?	30–200 µg/L (Normal/High)
72	What is the TIBC level in Anemia of Inflammation (AI)?	<300 µg/dL (Low)
73	What is the Serum Iron level in Anemia of Inflammation (AI)?	<50 µg/dL (Low)
74	What is the Serum Ferritin's significance in evaluation?	Most sensitive test for iron stores.
75	How does Inflammation affect Ferritin levels?	Increases threefold (masking IDA).
76	How is Transferrin Saturation calculated?	Ratio of Serum Iron to TIBC.
77	What Transferrin Saturation percentage indicates iron deficiency?	<20%
78	What is Hepcidin's role in Anemia of Inflammation?	Blocks iron release and absorption.
79	Which inflammatory cytokines (2) suppress EPO production?	TNF and INF-B
80	What is the primary cause of Anemia of Chronic Kidney Disease?	Decreased EPO production.
81	What is the morphology of Anemia of CKD?	Normocytic and normochromic.
82	Explain Anemia in Hypometabolic States.	Reduced O2 demand leads to decreased EPO.

HEMOGLOBIN DISORDERS AND TRANSFUSION

Count	Q	A
83	Why should Thalassemia patients in the Philippines not be treated with iron?	They have normal iron stores.
84	How does Sickle Hemoglobinopathy manifest (4)?	Pain, splenic infarction, stroke, CKD.
85	What is the standard hemoglobin threshold for transfusion?	<7 g/dL
86	When is transfusion indicated for hemoglobin 7–8 g/dL?	Cardiovascular instability.
87	When is transfusion indicated for hemoglobin 8–10 g/dL?	Patients with an active MI.
88	Under what condition is transfusion needed despite a normal Hgb level?	Active bleeding.

DIFFERENTIATION AND COMPARISON (THE CONFUSION FIXER)

Count	Q	A
89	Compare Ferritin and TIBC in IDA vs AI.	IDA: Low Ferritin, High TIBC. AI: High Ferritin, Low TIBC.
90	Contrast Absolute vs Relative Anemia.	Absolute: True mass decrease. Relative: Dilution by plasma volume.
91	Contrast Burr Cells vs Spur Cells.	Burr: Regular, Uremia. Spur: Irregular, Liver Disease.
92	List the MCV size categories.	Micro (<80), Normo (80-100), Macro (>100).
93	Contrast Anisocytosis vs Poikilocytosis.	Aniso: Size variation. Poikilo: Shape variation.
94	Interpret RPI <2 vs RPI >3.	<2: Production problem. >3: Hemolysis/Blood loss.
95	Contrast Megaloblastic vs Non-megaloblastic macrocytosis.	Megalo: Hypersegmented neutrophils. Non-megalo: No hypersegmented neutrophils.
96	Contrast Pasteur vs Warburg Effects.	Pasteur: Anaerobic response. Warburg: Malignant aerobic glycolysis.
97	Compare Alpha vs Beta Thalassemia electrophoresis.	Beta: Abnormal pattern. Alpha: Often normal pattern.
98	Contrast Serum Iron vs Ferritin.	Iron: Circulating iron. Ferritin: Total body stores.
99	Contrast Howell-Jolly vs Pappenheimer bodies.	Howell-Jolly: DNA remnants. Pappenheimer: Iron-containing inclusions.
100	Contrast Ferrous sulfate vs Sangobion elemental iron content.	Sulfate: 60 mg. Sangobion: 100-140 mg.
101	Why is sorbitol sometimes added to iron supplements?	To prevent iron-induced constipation.
102	Compare RDW in IDA vs Thalassemia.	High RDW: IDA. Normal RDW: Thalassemia.
103	List early deficiency states that cause High RDW (2).	IDA and B12 deficiency.
104	Contrast the Primary Problem in Anemia of CKD vs AI.	CKD: EPO deficiency. AI: Hepcidin/Iron sequestration.
105	What serum B12 level is considered normal?	200–900 ng/L
106	Contrast Stomatocytes vs Spherocytes.	Stomato: Mouth slit. Sphero: Dense, lacks pallor.
107	What is the WHO pregnancy cut-off for anemia?	Hemoglobin <11-12 g/dL

4.3

Summary

text [GENERAL BONE MARROW KNOWLEDGE]

[General Hematopoiesis] The most common RBC enzymatic deficiency is G6PD deficiency, which follows an X-linked pattern of inheritance.
[General Hematopoiesis] The most common enzymatic deficiency of the glycolytic pathway causing anemia is Pyruvate kinase deficiency.
[General Hematopoiesis] The two most common causes of megaloblastic anemia are Folate deficiency and Vitamin B12 deficiency.
[General Hematopoiesis] The firstmost hematopoietic location is the yolk sac, followed by the liver (main) and spleen (minor), and finally the bone marrow, specifically in flat bones.
[Bone Marrow Biopsy] The sternum and iliac crest are the standard examples of sites where bone marrow biopsies are taken.
[Bone Marrow Failure] In bone marrow failure, the clinician should expect pancytopenia, where all cell lines (RBC, WBC, Platelets) are low.
[Bone Marrow Failure] Aplastic anemia is the first disease that should come to mind when considering bone marrow failure.
[Bone Marrow Morphology] A hypocellular marrow is characterized by having very few hematopoietic cells that are replaced by fat, making the marrow look "empty" or yellow.
[Bone Marrow Morphology] Pancytopenia with cellular bone marrow can be caused by systemic diseases like Systemic Lupus Erythematosus (SLE).

TOPIC	PATHOGENESIS/ETIOLOGY	CLINICAL MANIFESTATIONS	DIAGNOSIS/LABS	TREATMENT
APLASTIC ANEMIA (AA)	Hematopoietic stem cell failure; Replacement of bone marrow by fat; Decreased CD34+ cells. *EBV is most notorious virus.	Bleeding (Most common early symptom); Pallor; Infection (unusual first symptom); LAD/Splenomegaly unlikely.	Pancytopenia with hypocellularity; Fat replaces >75% of marrow; Corrected retic <1%.	SCT (First choice for young); ATG + Cyclosporine; Eltrombopag; Androgens.
PURE RED CELL APLASIA (PRCA)	Isolated failure of erythropoeisis. Associated with Parvovirus B19 and Thymoma.	Anemia; Reticulocytopenia; "Slapped cheek" (if Fifth disease).	Absent erythroid precursors; BM shows Giant Pronormoblasts; WBC and Platelets are NORMAL.	Thymoma excision; IV Ig (for Parvovirus); Immunosuppression.
MYELODYSPLASTIC SYNDROME (MDS)	Clonal stem cell disorder; High risk for AML. Associated with benzene, radiation, and chemotherapy.	Disease of elderly males; Anemia; Neutrophil dysfunction; Splenomegaly (20%).	Normal or Hypercellular marrow; Hyposegmented neutrophils (Pelger-Huet); <20% blasts.	SCT (Only cure); Azacitidine/Decitabine (High risk); Lenalidomide (5q- syndrome).
MYELOPHTHISIC ANEMIA	Secondary myelofibrosis; Marrow replaced by fibrosis, tumors (epithelial cancer), or granulomas.	Anemia; Leucoerythroblastic smear; Massive splenomegaly; DRY TAP on marrow aspiration.	Tear-drop shaped RBCs (Dacrocytes); Immature myeloid cells in peripheral blood.	Treat underlying cause (e.g., cancer, infection, Gaucher disease).

[APLASTIC ANEMIA (AA)]

[AA - Epidemiology] Aplastic Anemia affects men and women equally and has a biphasic age distribution (teens-twenties and older adults).
[AA - Etiology] EBV (Epstein-Barr Virus) is the most notorious virus associated with the development of aplastic anemia.
[AA - Etiology] Chloramphenicol and Benzene (found in gasoline) are drugs and chemicals that have a consistent and drastic association with aplastic anemia.
[AA - Pathophysiology] The hallmark morphology of Aplastic Anemia is the replacement of bone marrow hematopoietic tissue by fat (yellow marrow).
[AA - Pathophysiology] CD34 cells are significantly decreased in Aplastic Anemia, along with an absence of committed and progenitor cells.
[AA - Clinical] Bleeding (petechiae, ecchymoses, mucosal) is the most common early symptom of Aplastic Anemia due to low platelets.
[AA - Clinical] Infection is an unusual first symptom in Aplastic Anemia; if present early, other causes like HIV or autoimmune diseases should be ruled out.
[AA - Clinical] Lymphadenopathy (LAD) and splenomegaly are highly unlikely in Aplastic Anemia and should prompt consideration of other diagnoses.
[AA - Clinical] Fanconi Anemia is a constitutional form of Aplastic Anemia characterized by Café au lait spots and short stature.
[AA - Clinical] Dyskeratosis Congenita is a constitutional form of Aplastic Anemia characterized by peculiar nails, leukoplakia, and telomerase defects (early graying).
[AA - Clinical Differentiation] Mucosal bleeding (gums, nose, GI) suggests a platelet problem, while cavity bleeding (joints/hemarthrosis, muscles) suggests a clotting factor deficiency.
[AA - Labs] Large RBCs (increased MCV) and a paucity of platelets and granulocytes are typical blood findings in Aplastic Anemia.
[AA - Labs] Absent reticulocytes are expected in Aplastic Anemia due to bone marrow failure and lack of production.
[AA - Labs] Immature myeloid forms in the blood suggest leukemia or MDS rather than true Aplastic Anemia.
[AA - Labs] Bone marrow in Aplastic Anemia typically shows fat with hematopoietic cells occupying less than 25% of the space.
[AA - Ancillary] Chromosome breakage studies are used to rule out Fanconi anemia in patients presenting with marrow failure.
[AA - Diagnosis] Severe Aplastic Anemia (*) is diagnosed if at least 2 of 3 criteria are met: ANC <500, Platelet count <20,000, and Corrected reticulocyte count <1% (or absolute <60,000).
[AA - Treatment] Hematopoietic Stem Cell Transplantation (SCT) is the first choice for younger patients with a fully histocompatible sibling donor (*).
[AA - Treatment] ATG (Antithymocyte globulin) + Cyclosporine + Methylprednisolone is the standard immunosuppression regimen for Aplastic Anemia (*).
[AA - Treatment] Eltrombopag is a thrombopoietin mimetic used for refractory Aplastic Anemia.
[AA - Treatment] Androgens (e.g., Testosterone) are used because they upregulate telomerase gene activity.
[AA - Treatment] Iron chelators should be started after the 50th transfusion to avoid hemochromatosis.
[AA - Treatment] NSAIDs should be avoided in Aplastic Anemia due to the risk of bleeding and inhibition of thromboxane A2.

[PURE RED CELL APLASIA (PRCA)]

[PRCA - Definition] Pure Red Cell Aplasia is characterized by anemia, reticulocytopenia, and the absence of erythroid precursors in the marrow, while WBCs and platelets remain normal.
[PRCA - Etiology] Parvovirus B19 and Thymoma (*) are the two most common causes of Pure Red Cell Aplasia.
[PRCA - Etiology] Diamond-Blackfan Anemia is a congenital form of PRCA that responds to glucocorticoid treatment.
[PRCA - Etiology] Parvovirus B19 infection causes "slapped cheek" (Fifth disease) in children and can trigger a transient aplastic crisis.
[PRCA - Morphology] Giant Pronormoblasts in the bone marrow are a hallmark of Parvovirus B19 induced Pure Red Cell Aplasia.
[PRCA - Treatment] Thymoma excision is the treatment for thymoma-associated PRCA, although the anemia does not always improve post-surgery.

[MYELODYSPLASTIC SYNDROMES (MDS)]

[MDS - Definition] Myelodysplastic Syndromes are a group of clonal stem cell disorders characterized by cytopenias due to marrow failure and a high risk of transformation to AML.
[MDS - Epidemiology] MDS is primarily a disease of the elderly, with a higher prevalence in males.
[MDS - Etiology] Benzene, radiation, and chemotherapy (busulfan, nitrosourea, topoisomerase inhibitors) are known environmental triggers for MDS.
[MDS - Clinical] Sweet’s syndrome (febrile neutrophilic dermatosis) is a skin manifestation that can be seen in MDS patients.
[MDS - Clinical] Children with Down Syndrome are particularly susceptible to developing MDS.
[MDS - Labs] Hypogranulated and hyposegmented neutrophils (Dohle bodies) are characteristic peripheral blood findings in MDS.
[MDS - Labs] Circulating myeloblasts in MDS are a poor prognostic factor indicating potential progression to leukemia.
[MDS - Labs] Bone marrow in MDS is typically normal or hypercellular, differentiating it from the hypocellularity of Aplastic Anemia.
[MDS - Prognosis] Monosomy 7 (presence of only one chromosome 7) is associated with severe pancytopenia and a poor prognosis in MDS.
[MDS - Diagnosis] Acute Myeloid Leukemia (AML) is defined by having ≥20% blasts in the bone marrow; MDS has fewer.
[MDS - Treatment] Allogenic Hematopoietic SCT is the only treatment that offers a potential cure for MDS.
[MDS - Treatment] Azacitidine and Decitabine are hypomethylating agents used for high-risk MDS patients.
[MDS - Treatment] Lenalidomide is highly effective for reversing anemia in MDS patients with the 5q- syndrome.
[MDS - Treatment] Luspatercept treats anemia by affecting TGF-β mediated suppression of erythropoiesis.
[MDS - Treatment] Venetoclax is an inhibitor of the BCL2 protein used to increase apoptosis in MDS cells.

[MYELOPHTHISIC ANEMIAS]

[Myelophthisis - Definition] Myelophthisic Anemias are caused by secondary reactive fibrosis in the marrow space due to cancer, infection (HIV, TB), or storage diseases (Gaucher).
[Myelophthisis - Clinical] Leucoerythroblastic smear featuring immature red and white cells is a hallmark of Myelophthisic Anemia.
[Myelophthisis - Clinical] Tear drop-shaped RBCs (Dacrocytes) are characteristic of Myelophthisis as cells squeeze through fibrotic marrow or the spleen.
[Myelophthisis - Diagnosis] A DRY tap during bone marrow aspiration is common in Myelophthisic Anemia because the marrow is replaced by fiber rather than fluid.

TOPIC	UNIQUE MUTATION / DRIVER	KEY CLINICAL CLINCHERS	EPO LEVEL	TREATMENT
POLYCYTHEMIA VERA (PV)	JAK2 V617F (Valine → Phenylalanine); Chromosome 9p.	Aquagenic pruritus (itchy after shower); Erythromelalgia; Budd-Chiari syndrome.	LOW/Suppressed	Phlebotomy (Hct <45% M, <42% F); Aspirin; Hydroxyurea; Ruxolitinib.
PRIMARY MYELOFIBROSIS (PMF)	JAK2, MPL, CALR mutations (*).	Massive splenomegaly; Tear-drop RBCs; Dry tap on BM; Night sweats/Weight loss.	Variable	SCT (Only cure); Ruxolitinib; Splenectomy (palliation).
ESSENTIAL THROMBOCYTOSIS (ET)	JAK2, MPL, CALR mutations.	Overproduction of platelets; Hemorrhagic and thrombotic tendencies; F > M.	Normal	Hydroxyurea + Aspirin; Anagrelide; Smoking cessation.

[POLYCYTHEMIA VERA (PV)]

[PV - Definition] Polycythemia Vera is the most common myeloproliferative neoplasm (MPN), characterized by the overproduction of all myeloid cells without a physiologic stimulus.
[PV - Etiology] The JAK2 V617F mutation (*) involves a valine to phenylalanine substitution, causing constitutive tyrosine kinase signaling and EPO-independent erythropoiesis.
[PV - Clinical] Aquagenic pruritus is a classic symptom of PV where the patient feels itchy after showering or contact with water.
[PV - Clinical] Erythromelalgia is a unique PV symptom featuring red, warm, and painful extremities due to microvascular thrombosis.
[PV - Clinical] Budd-Chiari syndrome (hepatic vein thrombosis) should prompt suspicion of PV, especially in young women.
[PV - Clinical] Hyperviscosity in PV causes neurologic symptoms like vertigo, tinnitus, visual disturbances, and transient ischemic attacks (TIAs).
[PV - Clinical] Acquired von Willebrand's disease can occur in PV (and ET) due to high platelet counts leading to increased proteolysis of vWF multimers.
[PV - Labs] Low to Normal Serum EPO suggests PV as the cause of elevated hemoglobin, whereas High EPO suggests secondary polycythemia (e.g., hypoxia).
[PV - Treatment] Phlebotomy is used to reach target goals: Hemoglobin 14 g/dL and Hct <45% in males, and Hemoglobin 12 g/dL and Hct <42% in females.
[PV - Treatment] Ruxolitinib is a JAK1/2 inhibitor used for PV patients with splenomegaly or generalized pruritus.
[PV - Treatment] Hydroxyurea is a common chemotherapy for PV but has leukemogenic potential (can transform to leukemia).

[PRIMARY MYELOFIBROSIS (PMF)]

[PMF - Definition] Primary Myelofibrosis is the least common MPN, characterized by a "woody" or "tree bark-like" fibrotic bone marrow and massive splenomegaly.
[PMF - Etiology] The mutation triad for PMF (*) includes mutations in JAK2 (55%), CALR, or MPL.
[PMF - Clinical] Extramedullary hematopoiesis (EMH) in PMF causes massive splenomegaly and can lead to complications like portal hypertension or spinal cord compression.
[PMF - Clinical] Splenic infarction in PMF patients presents with fever, left upper quadrant (LUQ) pain, and pleuritic chest pain.
[PMF - Diagnosis] Tear-drop shaped RBCs on a peripheral smear are indicative of membrane damage from passage through a fibrotic marrow or the spleen.
[PMF - Treatment] Allogenic bone marrow transplantation is the only curative treatment for Primary Myelofibrosis.

[ESSENTIAL THROMBOCYTOSIS (ET)]

[ET - Definition] Essential Thrombocytosis is characterized by the overproduction of platelets without a definable cause, predominantly affecting females.
[ET - Clinical] Spurious hyperkalemia can occur in ET labs due to the release of potassium from high concentrations of platelets during clotting in the test tube.
[ET - Diagnosis] Bone marrow biopsy in ET shows megakaryocyte hypertrophy and hyperplasia.
[ET - Complications] Tobacco use is the most important risk factor for thrombosis in patients with Essential Thrombocytosis.
[ET - Treatment] Aspirin should NOT be given to ET patients with an acquired von Willebrand disease (platelet count >1,000,000) as it increases bleeding risk.
[ET - Treatment] Anagrelide is a non-cytotoxic platelet-lowering agent used in Essential Thrombocytosis.

TOPIC	M-PROTEIN TYPE	KEY CLINICAL CLINCHERS	RADIOLOGY
MULTIPLE MYELOMA (MM)	IgG (53%) or IgA (25%)	CRAB: Hypercalcemia, Renal failure, Anemia, Bone lesions.	Lytic (punched out) lesions.
WALDENSTRÖM’S (WM)	IgM (Pentamer)	Hyperviscosity; Organomegaly; No bone lesions.	Normal bones.
POEMS SYNDROME	Monoclonal (M-spike)	Polyneuropathy, Organomegaly, Endocrinopathy, Skin changes.	Sclerotic bone lesions.
HEAVY CHAIN DISEASES	Heavy chains ONLY	Palatal edema (Gamma); Malabsorption (Alpha); CLL variant (Mu).	Variable.

[PLASMA CELL DISORDERS]

[Plasma Cell Disorders] Plasma cells are derived from B-lymphocytes and are responsible for producing antibodies (immunoglobulins).
[Multiple Myeloma (MM) - Etiology] IL-6 is the key driver cytokine that promotes plasma cell proliferation in Multiple Myeloma.
[MM - Clinical] The CRAB criteria for Multiple Myeloma includes: Calcium (elevated), Renal failure, Anemia, and Bone lesions.
[MM - Clinical] Bone pain is the most common symptom of Multiple Myeloma, resulting from increased osteoclast activity and lytic lesions.
[MM - Clinical] Bence Jones protein refers to monoclonal light chains found in the urine of Multiple Myeloma patients.
[MM - Labs] Serum protein electrophoresis (SPEP) shows a sharp "church spire" spike in the M component in monoclonal gammopathies.
[MM - Labs] A decreased anion gap in MM is caused by the presence of cationic M proteins.
[MM - Prognosis] β2-microglobulin is the best predictor of prognosis and a key component of the ISS staging for Multiple Myeloma.
[MM - Treatment] Lenalidomide + Bortezomib + Dexamethasone (RVD) is a standard first-line triplet regimen for MM.
[MM - Treatment] Autologous stem cell transplant is the standard of care for eligible MM patients but is not curative.
[Waldenström’s Macroglobulinemia (WM)] IgM secretion in WM causes hyperviscosity syndrome (headache, visual disturbance) and organomegaly, but unlike MM, there are no lytic bone lesions.
[WM - Pathophysiology] The MYD88 L265P mutation is found in >90% of Waldenström’s macroglobulinemia cases.
[WM - Morphology] Rouleaux formation (RBCs stacked like coins) is commonly seen on the peripheral smear in Waldenström’s.
[POEMS Syndrome] POEMS syndrome features sclerotic bone lesions, which differ from the lytic lesions seen in Multiple Myeloma.
[Heavy Chain Disease] Gamma heavy chain disease (Franklin’s) is classic for causing palatal edema which may compromise the airway.
[Heavy Chain Disease] Alpha heavy chain disease (Seligmann’s) is associated with Mediterranean lymphoma (IPSID) and Campylobacter jejuni, causing malabsorption.

[COMPARISON TIPS FOR EXAMS]

[Differentiation: Bleeding History] In platelet disorders, bleeding is mucosal (gums, epistaxis), while in clotting factor deficiencies (like Hemophilia), bleeding is into cavities (joints, muscles).
[Differentiation: Bone Marrow Failure] Aplastic Anemia presents with a hypocellular (empty) marrow, whereas MDS presents with a hypercellular or normal marrow with "sick-looking" (dysplastic) cells.
[Differentiation: PCV vs Secondary Polycythemia] Polycythemia Vera has LOW serum EPO levels, while Secondary Polycythemia (from smoking or high altitude) has HIGH serum EPO levels.
[Differentiation: Myeloproliferative Neoplasms] Polycythemia Vera is dominated by RBC elevation; Essential Thrombocytosis is dominated by Platelet elevation (>450,000); and Primary Myelofibrosis is dominated by marrow fibrosis and massive splenomegaly.
[Differentiation: Fibrosis vs Replacement] Myelofibrosis is primary neoplastic fibrosis of the marrow, whereas Myelophthisis is marrow replacement secondary to other causes like cancer or TB.
[Differentiation: MM vs WM] Multiple Myeloma is characterized by lytic bone lesions, renal failure, and hypercalcemia; Waldenström’s is characterized by IgM, hyperviscosity, and organomegaly (no bone lesions).
[Differentiation: Bone Lesions] Multiple Myeloma shows lytic (dark/punched out) lesions, while POEMS syndrome shows sclerotic (bright/dense) bone lesions.
[Differentiation: PRCA] Pure Red Cell Aplasia only affects the RBC line, whereas Aplastic Anemia affects all cell lines (pancytopenia).
[Differentiation: Reticulocytes] Reticulocyte count is almost zero in Aplastic Anemia and PRCA (failure of production), whereas it may be high in states of peripheral destruction (hemolysis) or bleeding.
[Differentiation: MDS vs Myeloproliferative] MDS is a disorder of "dysfunction" (low counts, high risk AML), while Myeloproliferative Neoplasms (MPNs) are disorders of "excess" (high counts).
[Differentiation: Chromosomes] Monosomy 7 in MDS signals a poor prognosis, while the 5q- syndrome in MDS responds very well to Lenalidomide.
[Differentiation: Mutations] JAK2 V617F is present in >95% of PV cases, but only ~50-60% of ET and PMF cases.
[Differentiation: Leukoplakia] Leukoplakia in Dyskeratosis Congenita is a white patch that cannot be scraped off; if it can be scraped off, think Oral Candidiasis.
[Differentiation: Splenomegaly] Splenomegaly is a hallmark of Primary Myelofibrosis and is common in Waldenström’s, but it is highly UNLIKELY in Aplastic Anemia.
[Differentiation: Etiology] Parvovirus B19 causes transient PRCA, while EBV is more linked to total bone marrow failure (Aplastic Anemia).
[Differentiation: Platelet Counts] In Essential Thrombocytosis, bleeding can occur despite high platelet counts if the count is >1 million, because it causes an "acquired von Willebrand disease."
[Differentiation: Treatment] Hydroxyurea is used in PV and ET to lower counts, but it is avoided in PMF where ruxolitinib is preferred for splenomegaly.
[Differentiation: Diagnosis] A DRY TAP on bone marrow aspiration is classically associated with Myelofibrosis and Myelophthisis due to collagen/fibers.
[Differentiation: PV Pruritus] Aquagenic pruritus is itchiness after water contact, which is relatively unique to Polycythemia Vera among the blood cancers.
[Differentiation: MM Staging] In Multiple Myeloma, use β2-microglobulin and albumin for staging; do NOT rely only on the size of the M-spike for stage.

QA

Count	Q	A
	GENERAL BONE MARROW KNOWLEDGE
1	What is the most common RBC enzymatic deficiency in General Hematopoiesis and its inheritance pattern?	G6PD deficiency; X-linked inheritance.
2	What is the most common enzymatic deficiency of the glycolytic pathway causing anemia in General Hematopoiesis?	Pyruvate kinase deficiency.
3	What are the two most common causes of megaloblastic anemia in General Hematopoiesis?	Folate and Vitamin B12 deficiency.
4	Enumerate the chronological sequence of hematopoietic locations in General Hematopoiesis. (4)	1) Yolk sac 2) Liver (main) 3) Spleen (minor) 4) Bone marrow (flat bones)
5	What are the standard example sites for a Bone Marrow Biopsy?	Sternum and iliac crest.
6	What blood count finding is expected in Bone Marrow Failure?	Pancytopenia; All cell lines (RBC, WBC, Platelets) are low.
7	Which specific disease is the first to consider regarding Bone Marrow Failure?	Aplastic anemia.
8	Describe the appearance of a hypocellular marrow in bone marrow morphology.	"Empty" or yellow; Hematopoietic cells are replaced by fat.
9	What systemic disease can cause pancytopenia with cellular bone marrow?	Systemic Lupus Erythematosus (SLE).
	SUMMARY: BONE MARROW FAILURE & MDS
10	What is the pathogenesis and most notorious viral link for Aplastic Anemia?	Stem cell failure; Marrow replaced by fat; Epstein-Barr Virus (EBV).
11	What are the clinical manifestations and likely organ involvement in Aplastic Anemia?	Bleeding, Pallor, Infection; LAD and Splenomegaly are unlikely.
12	What are the diagnostic laboratory findings for Aplastic Anemia?	Pancytopenia, Hypocellularity; Fat >75% of marrow, Corrected reticulocyte count <1%.
13	What are the treatment options for Aplastic Anemia?	Stem Cell Transplant (younger); ATG + Cyclosporine, Eltrombopag, and Androgens.
14	What is the etiology and associated conditions of Pure Red Cell Aplasia (PRCA)?	Erythropoiesis failure; Associated with Parvovirus B19 and Thymoma.
15	What are the hallmark diagnostic findings in the bone marrow and blood for Pure Red Cell Aplasia (PRCA)?	Absent erythroid precursors; Giant Pronormoblasts; Normal WBC and Platelets.
16	What is the etiology and risk associated with Myelodysplastic Syndrome (MDS)?	Clonal stem cell disorder; High risk for Acute Myeloid Leukemia (AML).
17	Describe the neutrophils and marrow cellularity found in Myelodysplastic Syndrome (MDS).	Hyposegmented (Pelger-Huet); Normal or Hypercellular bone marrow.
18	What is the hallmark clinical finding and marrow aspiration result for Myelophthisic Anemia?	Leucoerythroblastic smear; Massive splenomegaly and DRY TAP.
19	What specific RBC morphology is seen in Myelophthisic Anemia?	Tear-drop shaped RBCs (Dacrocytes).
	APLASTIC ANEMIA (AA)
20	What is the epidemiology and age distribution of Aplastic Anemia?	Affects genders equally; Biphasic (teens-twenties and older adults).
21	Which virus is most notorious for causing Aplastic Anemia?	Epstein-Barr Virus (EBV).
22	Which specific drug and chemical are drastically associated with Aplastic Anemia?	Chloramphenicol and Benzene.
23	What is the hallmark morphology of Aplastic Anemia?	Yellow marrow; Replacement of hematopoietic tissue by fat.
24	Which cell surface marker is significantly decreased in Aplastic Anemia?	CD34 cells.
25	What is the most common early symptom of Aplastic Anemia and why?	Bleeding; Due to low platelets (Thrombocytopenia).
26	Is infection a common first symptom of Aplastic Anemia?	No, it is unusual; Early infection suggests HIV or autoimmune causes.
27	How does the absence of LAD and splenomegaly help diagnose Aplastic Anemia?	Their presence suggests other diagnoses; They are highly unlikely in true Aplastic Anemia.
28	What are the clinical features of the constitutional form Fanconi Anemia?	Café au lait spots; Short stature and marrow failure.
29	What are the triad of symptoms for Dyskeratosis Congenita?	Peculiar nails, leukoplakia; Telomerase defects (early graying).
30	Compare Mucosal vs Cavity bleeding in clinical differentiation.	Mucosal (Platelet problem); Cavity (Clotting factor deficiency).
31	What are the typical blood findings (RBC size and counts) in Aplastic Anemia?	Large RBCs (increased MCV); Paucity of platelets and granulocytes.
32	What reticulocyte finding is expected in Aplastic Anemia?	Absent reticulocytes.
33	What do immature myeloid forms in blood suggest instead of Aplastic Anemia?	Leukemia or Myelodysplastic Syndrome.
34	What percentage of hematopoietic cells defines the bone marrow in Aplastic Anemia?	Less than 25% cellularity.
35	How is Fanconi Anemia ruled out in marrow failure patients?	Chromosome breakage studies.
36	What are the criteria for Severe Aplastic Anemia? (3)	1) ANC < 500 2) Platelets < 20,000 3) Corrected reticulocytes < 1%
37	What is the first-choice treatment for young Aplastic Anemia patients with a sibling donor?	Hematopoietic Stem Cell Transplantation.
38	What is the standard triple immunosuppression regimen for Aplastic Anemia?	ATG + Cyclosporine + Methylprednisolone.
39	What is the role of Eltrombopag in Aplastic Anemia?	Thrombopoietin mimetic; Used for refractory cases.
40	Why are Androgens (e.g., Testosterone) used in Aplastic Anemia?	Upregulate telomerase gene activity.
41	When should Iron chelators be started in Aplastic Anemia treatment?	After the 50th transfusion; To avoid hemochromatosis.
42	Why are NSAIDs avoided in Aplastic Anemia?	Risk of bleeding; Inhibition of thromboxane A2.
	PURE RED CELL APLASIA (PRCA)
43	Define Pure Red Cell Aplasia in terms of cell lines affected.	Isolated anemia/reticulocytopenia; Normal WBCs and platelets.
44	What are the two most common causes of Pure Red Cell Aplasia?	Parvovirus B19 and Thymoma.
45	What is Diamond-Blackfan Anemia and its treatment?	Congenital PRCA; Responds to glucocorticoid treatment.
46	What clinical sign does Parvovirus B19 cause in children?	"Slapped cheek" (Fifth disease).
47	What marrow finding is a hallmark of Parvovirus B19 induced Pure Red Cell Aplasia?	Giant Pronormoblasts.
48	What is the treatment for thymoma-associated Pure Red Cell Aplasia?	Thymoma excision.
	MYELODYSPLASTIC SYNDROMES (MDS)
49	Define the nature of Myelodysplastic Syndromes.	Clonal stem cell disorders; Characterized by marrow failure and risk of AML.
50	What is the epidemiology (age/gender) of Myelodysplastic Syndromes?	Elderly males.
51	List three environmental triggers for Myelodysplastic Syndromes.	1) Benzene 2) Radiation 3) Chemotherapy
52	What skin manifestation is associated with Myelodysplastic Syndromes?	Sweet’s syndrome; Febrile neutrophilic dermatosis.
53	Which pediatric population is highly susceptible to Myelodysplastic Syndromes?	Children with Down Syndrome.
54	Describe the neutrophils found in Myelodysplastic Syndromes peripheral blood.	Hypogranulated and hyposegmented; Dohle bodies may be present.
55	What is the prognostic significance of circulating myeloblasts in Myelodysplastic Syndromes?	Poor prognostic factor; Indicates potential AML progression.
56	Compare bone marrow cellularity in MDS vs Aplastic Anemia.	MDS is normal or hypercellular; Aplastic Anemia is hypocellular.
57	Which chromosomal abnormality in MDS is associated with poor prognosis?	Monosomy 7.
58	What blast percentage threshold differentiates AML from MDS?	AML is ≥ 20% blasts.
59	What is the only curative treatment for Myelodysplastic Syndrome?	Allogeneic Hematopoietic Stem Cell Transplant.
60	What are Azacitidine and Decitabine used for in MDS?	Hypomethylating agents; Used for high-risk patients.
61	Which drug is highly effective for 5q- syndrome in MDS?	Lenalidomide.
62	How does Luspatercept treat anemia in MDS?	Affects TGF-beta pathways; Reverses suppression of erythropoiesis.
63	What is the mechanism of Venetoclax in MDS treatment?	BCL2 protein inhibitor; Increases apoptosis in MDS cells.
	MYELOPHTHISIC ANEMIAS
64	What causes the secondary fibrosis in Myelophthisic Anemias?	Cancer, infection (HIV, TB); Or storage diseases (Gaucher).
65	Define the hallmark peripheral blood smear in Myelophthisic Anemia.	Leucoerythroblastic smear; Immature red and white cells.
66	Why do Dacrocytes (tear-drop RBCs) form in Myelophthisis?	Cells squeeze through fibrotic marrow; Or through the spleen.
67	Why is a DRY tap common in Myelophthisic Anemia?	Marrow replaced by fiber; Lack of aspiratable fluid.
	MYELOPROLIFERATIVE NEOPLASMS (MPN) SUMMARY
68	What is the mutation, key clinical sign, and EPO level in Polycythemia Vera (PV)?	JAK2 V617F; Aquagenic pruritus; LOW Serum Erythropoietin (EPO).
69	What is the treatment goal and method for Polycythemia Vera (PV)?	Phlebotomy; Target Hematocrit <45% (M) or <42% (F).
70	What are the mutation triad and key exam findings for Primary Myelofibrosis (PMF)?	JAK2, MPL, CALR; Massive splenomegaly and "Woody" marrow.
71	What is the mainstay treatment and the only cure for Primary Myelofibrosis (PMF)?	Curative: Stem Cell Transplant; Symptom control: Ruxolitinib.
72	What is the driver mutation and primary lab feature of Essential Thrombocytosis (ET)?	JAK2, MPL, CALR; Overproduction of platelets (Platelets > 450,000).
73	What unique agent is used to lower platelets in Essential Thrombocytosis (ET)?	Anagrelide.
	POLYCYTHEMIA VERA (PV)
74	Define Polycythemia Vera as a myeloproliferative neoplasm.	Overproduction of all myeloid cells; Occurs without a physiologic stimulus.
75	Describe the specific amino acid change in the JAK2 V617F mutation in PV.	Valine to Phenylalanine.
76	What is Aquagenic pruritus in PV?	Itchiness after contact with water; Classically after showering.
77	What are the symptoms of Erythromelalgia in PV?	Red, warm, painful extremities; Due to microvascular thrombosis.
78	Which thrombotic syndrome in young women should prompt a Polycythemia Vera workup?	Budd-Chiari syndrome; Hepatic vein thrombosis.
79	What neurologic symptoms are caused by hyperviscosity in PV?	Vertigo, tinnitus; Transient Ischemic Attacks (TIAs).
80	Why can PV patients develop acquired von Willebrand's disease?	High platelets; Increased proteolysis of vWF multimers.
81	Differentiate PV vs Secondary Polycythemia using serum EPO.	PV: Low Serum EPO; Secondary: High Serum EPO.
82	What are the Hct/Hemoglobin goals for men and women in PV Phlebotomy?	Men: Hct <45% (Hb 14); Women: Hct <42% (Hb 12).
83	What is the role of Ruxolitinib in Polycythemia Vera?	JAK1/2 inhibitor; Used for splenomegaly or pruritus.
84	What is the major concern when using Hydroxyurea in PV?	Leukemogenic potential; Can transform to leukemia.
	PRIMARY MYELOFIBROSIS (PMF)
85	Describe the bone marrow appearance in Primary Myelofibrosis.	"Woody" or "Tree bark-like"; Fibrotic marrow.
86	What percentage of JAK2 mutations are found in Primary Myelofibrosis?	Approximately 55%.
87	What complications can arise from extramedullary hematopoiesis in PMF?	Massive splenomegaly; Portal hypertension or spinal compression.
88	How does Splenic infarction present in PMF?	Fever, LUQ pain; Pleuritic chest pain.
89	What is the significance of Tear-drop shaped RBCs in PMF?	Membrane damage; Passed through fibrotic marrow or spleen.
90	What is the only curative modality for Primary Myelofibrosis?	Allogeneic bone marrow transplantation.
	ESSENTIAL THROMBOCYTOSIS (ET)
91	Define the primary abnormality in Essential Thrombocytosis.	Overproduction of platelets; Without a definable cause.
92	What is spurious hyperkalemia in the context of ET?	Artifactual high potassium; Platelets release potassium during clotting.
93	What are the findings of an ET bone marrow biopsy?	Megakaryocyte hypertrophy; Megakaryocyte hyperplasia.
94	What is the most important risk factor for thrombosis in Essential Thrombocytosis?	Tobacco use.
95	When is Aspirin contraindicated in Essential Thrombocytosis?	Acquired vWF disease; Platelet count > 1,000,000.
96	Describe the mechanism of Anagrelide in ET.	Non-cytotoxic; Platelet-lowering agent.
	PLASMA CELL DISORDERS SUMMARY
97	What are the M-protein type and classic clinical criteria for Multiple Myeloma (MM)?	IgG (53%) or IgA (25%); CRAB: Hypercalcemia, Renal, Anemia, Bone lesions.
98	Describe the bone lesions in Multiple Myeloma vs POEMS syndrome.	MM: Lytic (punched out); POEMS: Sclerotic (bright/dense).
99	What is the M-protein type and key clinical sign of Waldenström’s Macroglobulinemia?	IgM (Pentamer); Hyperviscosity syndrome.
100	What are the components of POEMS syndrome?	Polyneuropathy, Organomegaly; Endocrinopathy, Skin changes (and M-spike).
101	Match the clinical variants to Gamma and Alpha Heavy Chain Diseases.	Gamma: Palatal edema; Alpha: Malabsorption (Mediterranean lymphoma).
	PLASMA CELL DISORDERS DETAILS
102	From which cell type are Plasma cells derived and what is their function?	B-lymphocytes; Producing antibodies (immunoglobulins).
103	Which cytokine is the key driver of plasma cell proliferation in Multiple Myeloma?	IL-6 (Interleukin-6).
104	What is the most common symptom of Multiple Myeloma?	Bone pain.
105	Define Bence Jones protein in Multiple Myeloma.	Monoclonal light chains; Found in the urine.
106	What is seen on SPEP in Multiple Myeloma?	"Church spire" spike; Monoclonal M component.
107	Why does Multiple Myeloma cause a decreased anion gap?	Presence of cationic M proteins.
108	What is the best predictor of prognosis and ISS staging for Multiple Myeloma?	Beta-2-microglobulin.
109	What is the standard first-line triplet regimen (RVD) for MM?	Lenalidomide + Bortezomib + Dexamethasone.
110	Is Autologous stem cell transplant curative for Multiple Myeloma?	No, it is standard of care; But not curative.
111	Does Waldenström’s Macroglobulinemia typically present with lytic bone lesions?	No; Presents with hyperviscosity and organomegaly.
112	Which mutation is found in >90% of Waldenström’s macroglobulinemia cases?	MYD88 L265P.
113	Describe Rouleaux formation in Waldenström’s.	RBCs stacked like coins.
114	What is the etiology of Gamma heavy chain disease (Franklin’s)?	Airway-compromising palatal edema.
115	Which infectious agent is linked to Alpha heavy chain disease?	Campylobacter jejuni.
	COMPARISON TIPS FOR EXAMS
116	Compare Platelet vs Clotting factor bleeding sites.	Platelet: Mucosals (gums, nose); Clotting: Cavity (joints, muscles).
117	Differentiate Aplastic Anemia vs MDS marrow cellularity.	Aplastic: Hypocellular (empty); MDS: Hypercellular (dysplastic).
118	Differentiate PV vs Secondary Polycythemia by chemistry.	PV: LOW EPO; Secondary: HIGH EPO.
119	Compare the dominant features of the three Myeloproliferative Neoplasms (MPNs).	PV: RBCs; ET: Platelets; PMF: Fibrosis/Splenomegaly.
120	Differentiate Myelofibrosis vs Myelophthisis etiology.	Myelofibrosis: Primary neoplastic; Myelophthisis: Secondary (cancer/TB).
121	Compare clinical triads of MM vs WM.	MM: Lytic lesions/CRAB; WM: IgM/Hyperviscosity (No bone lesions).
122	Contrast Pure Red Cell Aplasia vs Aplastic Anemia cell lines.	PRCA: Only RBC line; Aplastic: All cell lines (Pancytopenia).
123	Describe Reticulocyte counts in marrow failure vs hemolysis.	Marrow Failure: Almost zero; Hemolysis/Bleeding: High.
124	Define MDS vs Myeloproliferative Neoplasms in terms of cell counts.	MDS: Dysfunction (low counts); MPN: Excess (high counts).
125	Match MDS chromosomes to prognosis/treatment.	Monosomy 7: Poor prognosis; 5q-: Good response to Lenalidomide.
126	Contrast JAK2 mutation frequency in PV vs ET/PMF.	PV: >95%; ET/PMF: ~50-60%.
127	How do you differentiate Leukoplakia from Oral Candidiasis?	Leukoplakia cannot be scraped off.
128	Is Splenomegaly common in Aplastic Anemia?	No, it is highly unlikely; Think PMF or WM instead.
129	Differentiate the primary viral link for PRCA vs Aplastic Anemia.	PRCA: Parvovirus B19; Aplastic Anemia: EBV.
130	When does Essential Thrombocytosis paradoxically cause bleeding?	Platelets > 1 million; Causes acquired von Willebrand disease.
131	Why is Hydroxyurea avoided in Primary Myelofibrosis?	Ruxolitinib is preferred for splenomegaly.
132	What causes a DRY TAP on marrow aspiration?	Collagen/Fibrosis; Seen in Myelofibrosis and Myelophthisis.
133	Which MPN is uniquely associated with Aquagenic pruritus?	Polycythemia Vera.
134	What are the preferred markers for Multiple Myeloma Staging?	Beta-2-microglobulin and albumin.

4.4

Summary

text

I. ANATOMIC CONSIDERATIONS AND GENERAL FUNCTIONS

For the GI Tract, the system extends from the mouth to the anus, with organs compartmentalized by sphincters to regulate flow.
The Mucosa layer of the gut wall acts as the primary site for nutrient absorption and provides a barrier against luminal contents.
The Smooth Muscle and Enteric Nerves are responsible for controlling propulsion (motility) and secretion throughout the GI tract.
The Serosa provides the gut with a supportive foundation and integrates external inputs from the systemic environment.
Lymphatic channels in the GI tract assist in gut immune activity, while intrinsic nerves regulate fluid and local propulsion.
In the Mouth, food is mixed with salivary amylase (also found in the pancreas) before being delivered to the pharynx.
The Lower Esophageal Sphincter (LES) maintains a basal tone to prevent gastroesophageal reflux; stretching of this sphincter (e.g., in obese or postpartum patients) increases GERD risk.
The Proximal Stomach serves a storage function by relaxing to accommodate meals.
The Distal Stomach uses phasic contractions to grind food against the pylorus and mixes it with pepsin and acid (trituration).
Gastric Acid serves two high-yield functions: sterilizing the upper gut and enabling the secretion of intrinsic factor for Vitamin B12 absorption.
The Small Intestine is the site where most nutrient absorption occurs, aided by villi which increase surface area.
The Duodenum is the site where food mixes with bile (essential for lipid digestion) and pancreatic juice (bicarbonate and enzymes).
The Ileum is the specific site for the absorption of bile acids and Vitamin B12.
The Ileocecal Valve acts as a sphincter to prevent colo-ileal reflux, thereby limiting the density of microbes in the small intestine.
The Colon primarily dehydrates stool via to-and-fro contractions; luminal volume decreases from ~1500 mL in the ileum to ~200 mL in the rectum.
The Liver provides a protective function by detoxifying drugs and toxins absorbed via the portal circulation.

II. CLASSIFICATION AND PATHOPHYSIOLOGY OF GI DISEASES

Topic/Category	Pathogenesis/Mechanism	Clinical Features/Examples
Maldigestion/Malabsorption	Deficiency in enzymes or transport	Lactase deficiency (Most common maldigestion syndrome); Gas/diarrhea with dairy.
Gastrointestinal Transit	Mechanical or functional blockage	Adhesions (Post-surgical; MC cause of SBO); Colorectal Cancer (MC cause of colonic obstruction).
Immune Dysregulation	Inflammatory response to triggers	Celiac disease (Gluten-triggered); IBD (Crohn’s and Ulcerative Colitis).
Vascular Supply	Reduced perfusion (Ischemia)	Severe pain out of proportion to exam; can lead to perforation or strictures.
DGBI (Gut-Brain Interaction)	Altered sensation/CNS processing	IBS and functional dyspepsia; NO structural abnormalities found on testing.

Type 3c Diabetes Mellitus is a specific form of diabetes secondary to exocrine pancreatic diseases like chronic pancreatitis or pancreatic cancer.
Lactase Deficiency is identified as the most common maldigestion syndrome, presenting with gas and diarrhea but no long-term adverse outcomes.
Small Bowel Obstruction is most commonly caused by adhesions following surgery; early ambulation is advised as a preventive measure.
Colonic Obstruction is most commonly caused by malignancy/cancer in adults.
Achalasia is a motility disorder characterized by decreased peristalsis and incomplete relaxation of the lower esophageal sphincter (LES).
Hyperthyroidism can manifest in the GI tract as hyperdefecation due to rapid transit.
Hypokalemia can cause functional constipation by altering gut transit through electrolyte imbalance.
Dysbiosis refers to alterations in the gut microbiome and is linked to IBD, IBS flares, and celiac disease.
Lynch Syndrome (HNPCC) is an autosomal dominant condition characterized by a few polyps, primarily in the proximal/right colon, and an increased risk of gynecologic cancers.
Familial Adenomatous Polyposis (FAP) is an autosomal dominant condition presenting with hundreds to thousands of polyps, primarily in the left colon.

III. CLINICAL MANIFESTATIONS AND DIAGNOSTICS

Visceral Pain is described as vague, dull, and midline in location.
Parietal Pain is localized and well-defined, often associated with inflammation of the peritoneum.
Under the 9 Regions of the Abdomen, RUQ pain (+ Murphy's sign) indicates cholecystitis, while RLQ pain at McBurney’s point suggests appendicitis.
Heartburn is a burning substernal sensation; patients are advised not to lie supine for at least 2 hours after eating to prevent reflux.
Upper GI Bleeding presents as hematemesis (vomiting blood) or melena (black, tarry stools); blood must stay in the stomach for ~14 hours to turn black.
Lower GI Bleeding typically presents as bright red blood per rectum (hematochezia), often from hemorrhoids or diverticula.
Mallory-Weiss Tears are mucosal lacerations at the gastroesophageal junction caused by severe retching, often related to alcohol use.
Dermatitis Herpetiformis is a unique skin manifestation specifically associated with Celiac disease.
Fecal Occult Blood Test (FOBT) is the primary tool for assessing chronic, non-visible (occult) GI bleeding leading to iron deficiency anemia.
Upper Endoscopy (EGD) is the first-line diagnostic for ulcers, esophagitis, and Barrett’s esophagus, though it is normal in 85% of dyspepsia cases.
Colonoscopy remains the gold standard for colorectal cancer (CRC) screening, typically starting at age 45.
Urea Breath Test and Stool Antigen tests are used to detect active H. pylori infection.

IV. ACUTE PANCREATITIS: ETIOLOGY AND PATHOGENESIS

Acute Pancreatitis is one of the most common inpatient GI diagnoses, with hospitalization rates increasing with age.
Gallstones are the leading cause of acute pancreatitis (30–60%); stones <5 mm are high-risk because they easily migrate and obstruct the ampulla of Vater.*****
Alcohol is the second most common cause of acute pancreatitis, accounting for 15–30% of cases.
Hypertriglyceridemia causes acute pancreatitis when serum TG levels exceed 1000 mg/dL.*****
DPP-4 Inhibitors (incretin therapy) are associated with an increased risk of acute pancreatitis, whereas GLP-1 agonists (like Ozempic) show no clear increased risk in Harrison's.
Autodigestion is the accepted pathogenic theory where proteolytic enzymes are activated within the pancreatic acinar cells rather than the duodenum.*****
Trypsin is the central enzyme in pancreatitis; once activated, it triggers other enzymes like elastase and phospholipase A2.
PSTI (SPINK1) is a protective protease inhibitor that normally inactivates about 20% of intracellular trypsin activity to prevent autodigestion.
PRSS1 (Cationic Trypsinogen Gene) mutations are unique because they are sufficient to precipitate acute pancreatitis without any other risk factors.
Low Intracellular Calcium in the acinar cell cytosol is protective, as it promotes the destruction of spontaneously activated trypsin.
In the Initial Phase of pancreatitis, trypsin activation is mediated by the lysosomal hydrolase cathepsin B.
The Third Phase of pancreatitis involves systemic effects, including SIRS, ARDS, and multiorgan failure.

V. ACUTE PANCREATITIS: ASSESSMENT AND DIAGNOSIS

Acute Pancreatitis Diagnosis requires 2 of 3 criteria: (1) typical epigastric pain radiating to the back, (2) Lipase/Amylase ≥3x ULN, (3) confirmatory imaging.
Serum Lipase is the preferred diagnostic test because it is more specific than amylase and remains elevated longer (7–14 days).
Serum Amylase can be spuriously low in cases of severe hypertriglyceridemia.
Serum ALT >3x ULN in the setting of pancreatitis is strongly associated with a gallstone etiology.
Cullen’s Sign is a faint blue discoloration around the umbilicus indicating hemoperitoneum.
Grey Turner’s Sign is a blue-red or green-brown discoloration of the flanks reflecting tissue breakdown of hemoglobin in severe necrotizing pancreatitis.
Pleural Effusion in acute pancreatitis occurs in 10-20% of cases and is most frequently left-sided.
Hematocrit >44% (hemoconcentration) and BUN >22 mg/dL (azotemia) on admission are strong predictors of more severe disease and higher mortality.
Abdominal Ultrasound is the recommended initial imaging modality to look for gallstones and ductal dilation.
CT Scan with Contrast should NOT be performed within the first 48 hours; it is best evaluated after 3–5 days to assess for local complications like necrosis.*****

VI. ACUTE PANCREATITIS: MANAGEMENT AND COMPLICATIONS

Fluid Resuscitation is the most important intervention; Lactated Ringer's (LR) is generally preferred over Normal Saline as it may decrease systemic inflammation.
Mild Acute Pancreatitis is self-limited, usually resolving in 3-7 days without organ failure; oral intake (low-fat solid diet) can be resumed quickly.
Severe Acute Pancreatitis is defined by persistent organ failure (>48 hours) involving the respiratory, cardiovascular, or renal systems.
BISAP Score (BUN >25, Impaired mental status, SIRS, Age >60, Pleural effusion) assesses in-hospital mortality risk within the first 24 hours.
Enteral Nutrition is preferred over TPN in severe pancreatitis because it maintains gut barrier integrity and limits bacterial translocation.*****
Prophylactic Antibiotics are NO longer recommended for severe acute pancreatitis as they do not improve survival and may promote fungal infections.
Infected Pancreatic Necrosis requires targeted antibiotics and definitive management via drainage or debridement.
Pancreatic Pseudocysts typically form 4–6 weeks after the onset of pancreatitis; only symptomatic ones require drainage.
Ascending Cholangitis in the setting of gallstone pancreatitis mandates an ERCP within 24–48 hours of admission.
Pancreatic Ascites results from pancreatic duct disruption; the ascitic fluid will have a high amylase level.
Splenic Vein Thrombosis is a localized vascular complication of pancreatitis that can lead to gastric varices.

VII. CHRONIC PANCREATITIS AND SECRETION REGULATION

Secretin is released by duodenal S cells in response to gastric acid and stimulates the secretion of water and bicarbonate from pancreatic ducts.
Cholecystokinin (CCK) is released by I cells in response to fats and amino acids, evoking an enzyme-rich secretion from acinar cells.
Bicarbonate in pancreatic juice is essential for neutralizing gastric acid and providing an optimal pH for digestive enzymes.
Enterokinase is an enzyme in the duodenal brush border that converts inactive trypsinogen into active trypsin.
Negative Feedback of pancreatic enzymes is mediated by trypsin; when proteases are free in the duodenum (late digestion), they blunt the CCK response.

COMPARISON CHALLENGE: DIFFERENTIATING KEY GI CONCEPTS

Visceral vs. Parietal Pain: Visceral pain is vague, dull, and midline (stretching of organs), while Parietal pain is sharp, well-localized, and associated with peritonitis/guarding.
Upper vs. Lower GI Bleed: Upper GI sources (above Ligament of Treitz) cause melena or hematemesis; Lower GI sources cause hematochezia (bright red blood).
Cullen's vs. Grey Turner's Sign: Cullen's is periumbilical (blue umbilicus); Grey Turner's is located on the flanks (sides). Both signify severe necrotizing pancreatitis.
Lynch Syndrome vs. FAP: Lynch has few polyps, right-sided colon, and extraintestinal cancers; FAP has >100 polyps, left-sided colon, and 100% cancer risk if untreated.
Amylase vs. Lipase: Amylase rises/falls quickly (short half-life) and is less specific; Lipase stays elevated longer (7-14 days) and is the preferred, more specific test.
Moderately Severe vs. Severe Pancreatitis: Mod-Severe features transient organ failure that resolves in <48 hours; Severe features persistent organ failure lasting >48 hours.
Secretin vs. CCK: Secretin stimulates bicarbonate and water (ductal cells); CCK stimulates digestive enzymes (acinar cells).
Interstitial vs. Necrotizing Pancreatitis: Interstitial shows homogenous gland enhancement on CT; Necrotizing shows a lack of parenchymal enhancement (interrupted blood supply).
Type 1 vs. Type 3c Diabetes: Type 1 is autoimmune destruction of beta cells; Type 3c is pancreatogenic, caused by exocrine pancreatic disease (pancreatitis/cancer).
Maldigestion vs. Malabsorption: Maldigestion is a failure of chemical breakdown (e.g., enzyme deficiency); Malabsorption is a failure of the mucosa to transport nutrients.
Gastric vs. Duodenal Ulcer Pain: Gastric ulcers are often aggravated by meals; Duodenal ulcers are often relieved by meals.
Lactose Intolerance vs. Celiac Disease: Lactose intolerance is a simple enzyme deficiency (no long-term damage); Celiac is an immune-mediated mucosal injury caused by gluten.
Secretory vs. Osmotic Diarrhea: Secretory diarrhea persists during fasting; Osmotic diarrhea (malabsorption) improves when the patient stops eating.
IBD vs. IBS: IBD (Crohn's/UC) is organic inflammation with visible damage/bleeding; IBS is a DGBI with no structural abnormalities.
PRSS1 vs. SPINK1: PRSS1 is a gain-of-function mutation in trypsinogen (autosomal dominant); SPINK1 is a loss-of-function mutation in a trypsin inhibitor.
Murphy's vs. McBurney's Point: Murphy's sign is RUQ pain on inspiration (Gallbladder); McBurney's point is RLQ tenderness (Appendix).
Psoas vs. Obturator Sign: Psoas is pain on hip extension; Obturator is pain on internal rotation of the flexed hip. Both indicate appendicitis.
Enteral vs. Parenteral Nutrition: Enteral (tube feeding) is preferred to maintain gut barrier; Parenteral (IV) is only for severe gut failure.
Prokinetics vs. Loperamide: Prokinetics increase motility (for gastroparesis); Loperamide decreases motility (for diarrhea).
HNPCC vs. CRC Screening Age: Normal CRC screening begins at 45; Lynch/HNPCC families require much earlier screening due to genetic risk.

QA

I. ANATOMIC CONSIDERATIONS AND GENERAL FUNCTIONS

Count	Q	A
1	From where does the GI Tract system extend and how are organs compartmentalized?	Mouth to anus; Sphincters.
2	What are the functions (2) of the Mucosa layer of the gut wall?	1) Nutrient absorption 2) Barrier against contents.
3	What functions (2) are the Smooth Muscle and Enteric Nerves responsible for?	1) Propulsion (motility) 2) Secretion.
4	What is the function of the Serosa in the gut wall?	Supportive foundation and integrating external inputs.
5	What are the roles of Lymphatic channels and intrinsic nerves in the GI tract?	Immune activity; Fluid/local propulsion.
6	In the Mouth, what enzyme is mixed with food before delivery to the pharynx?	Salivary amylase.
7	What is the function of the Lower Esophageal Sphincter (LES) and what increases GERD risk?	Maintains basal tone; Stretching/Obesity/Postpartum.
8	What is the primary function of the Proximal Stomach?	Storage function (relaxation).
9	What are the functions (2) of the Distal Stomach regarding food processing?	1) Grinding (trituration) 2) Mixing with pepsin/acid.
10	What are the two high-yield functions of Gastric Acid?	1) Sterilizing upper gut 2) Intrinsic factor secretion.
11	What is the primary site of nutrient absorption in the Small Intestine and what aids it?	Small intestine; Villi.
12	What components mix with food in the Duodenum for digestion?	Bile and Pancreatic juice.
13	The Ileum is the specific site for the absorption of which two substances?	1) Bile acids 2) Vitamin B12.
14	What is the function of the Ileocecal Valve?	Prevents colo-ileal reflux.
15	What is the primary function of the Colon and how much does luminal volume decrease?	Dehydrates stool; 1500 mL to 200 mL.
16	What protective function does the Liver provide?	Detoxifying drugs and toxins.

II. CLASSIFICATION AND PATHOPHYSIOLOGY OF GI DISEASES

Count	Q	A
17	What is the pathogenesis and most common example of Maldigestion/Malabsorption?	Enzyme/transport deficiency; Lactase deficiency.
18	What is the mechanism and most common cause of Gastrointestinal Transit blockage in the small bowel?	Mechanical/functional blockage; Adhesions (post-surgical).
19	What are the mechanisms of Immune Dysregulation and list two examples?	Inflammatory response; Celiac and IBD.
20	What is the mechanism of Vascular Supply disease and its classic clinical feature?	Reduced perfusion (Ischemia); Pain out of proportion.
21	What is the mechanism of DGBI (Gut-Brain Interaction) like IBS?	Altered sensation/CNS processing.
22	What is Type 3c Diabetes Mellitus?	Diabetes secondary to exocrine pancreatic disease.
23	What symptoms are associated with Lactase Deficiency?	Gas and diarrhea.
24	What is the most common cause of Small Bowel Obstruction?	Adhesions.
25	What is the most common cause of Colonic Obstruction in adults?	Malignancy/Cancer.
26	What are the features (2) of the motility disorder Achalasia?	1) Decreased peristalsis 2) Incomplete LES relaxation.
27	How does Hyperthyroidism typically manifest in the GI tract?	Hyperdefecation (rapid transit).
28	How does Hypokalemia affect gut transit?	Causes functional constipation.
29	What does the term Dysbiosis refer to?	Alterations in gut microbiome.
30	What are the features (3) of Lynch Syndrome (HNPCC)?	1) Few polyps 2) Proximal/Right colon 3) Gynecologic cancer risk.
31	What are the features (2) of Familial Adenomatous Polyposis (FAP)?	1) Hundreds of polyps 2) Primarily left colon.

III. CLINICAL MANIFESTATIONS AND DIAGNOSTICS

Count	Q	A
32	Describe the typical location and quality of Visceral Pain.	Vague, dull, midline.
33	What characterizes Parietal Pain?	Localized, well-defined, peritoneal inflammation.
34	What does RUQ pain with a positive Murphy's sign indicate under the 9 Regions of the Abdomen?	Cholecystitis.
35	What does RLQ pain at McBurney’s point suggest under the 9 Regions of the Abdomen?	Appendicitis.
36	What lifestyle advice is given for Heartburn to prevent reflux?	Do not lie supine for 2 hours.
37	How does Upper GI Bleeding present clinically (2)?	Hematemesis or Melena.
38	How long must blood stay in the stomach to produce Melena?	~14 hours.
39	How does Lower GI Bleeding typically present?	Hematochezia (bright red blood).
40	What are Mallory-Weiss Tears and what causes them?	Mucosal lacerations; Severe retching.
41	What unique skin manifestation is associated with Celiac disease?	Dermatitis Herpetiformis.
42	What is the primary tool for assessing chronic, non-visible Occult GI bleeding?	Fecal Occult Blood Test (FOBT).
43	What is the first-line diagnostic for ulcers and Barrett’s esophagus?	Upper Endoscopy (EGD).
44	What is the gold standard for Colonoscopy screening and at what age?	Colorectal cancer; Age 45.
45	Which tests (2) are used to detect active H. pylori infection?	Urea Breath and Stool Antigen.

IV. ACUTE PANCREATITIS: ETIOLOGY AND PATHOGENESIS

Count	Q	A
46	What is the leading cause of Acute Pancreatitis?	Gallstones (30–60%).
47	Why are gallstones <5 mm considered high-risk in pancreatitis?	Migrate and obstruct ampulla.
48	What is the second most common cause of Acute Pancreatitis?	Alcohol.
49	At what level does Hypertriglyceridemia cause acute pancreatitis?	>1000 mg/dL.
50	Which diabetic medication class is associated with Acute Pancreatitis risk?	DPP-4 Inhibitors.
51	What is the Autodigestion theory of pancreatitis pathogenesis?	Intracellular activation of proteolytic enzymes.
52	What is the central enzyme in Pancreatitis that triggers other enzymes?	Trypsin.
53	Which enzymes (2) are triggered once trypsin is activated in Pancreatitis?	Elastase and Phospholipase A2.
54	What is the function of PSTI (SPINK1)?	Inactivates intracellular trypsin.
55	What is unique about PRSS1 mutations?	Precipitates pancreatitis without other factors.
56	Why is Low Intracellular Calcium protective in acinar cells?	Promotes destruction of active trypsin.
57	Which enzyme mediates trypsin activation in the Initial Phase of pancreatitis?	Cathepsin B.
58	What systemic effects occur in the Third Phase of pancreatitis (3)?	SIRS, ARDS, Multiorgan failure.

V. ACUTE PANCREATITIS: ASSESSMENT AND DIAGNOSIS

Count	Q	A
59	What are the 3 criteria for Acute Pancreatitis Diagnosis (requires 2 of 3)?	1) Epigastric pain 2) Lipase/Amylase ≥3x ULN 3) Imaging.
60	Why is Serum Lipase preferred over amylase?	More specific; Remains elevated longer.
61	What can cause Serum Amylase to be spuriously low?	Severe hypertriglyceridemia.
62	What does a Serum ALT >3x ULN suggest in pancreatitis?	Gallstone etiology.
63	Define Cullen’s Sign.	Blue discoloration around umbilicus.
64	Define Grey Turner’s Sign.	Discoloration of the flanks.
65	On which side is a Pleural Effusion most frequently found in pancreatitis?	Left-sided.
66	Which admission labs (2) are strong predictors of Severe Pancreatitis?	Hematocrit >44%; BUN >22 mg/dL.
67	What is the recommended Initial Imaging modality for pancreatitis?	Abdominal Ultrasound.
68	When is the best time to perform a CT Scan with Contrast for local complications?	After 3–5 days.

VI. ACUTE PANCREATITIS: MANAGEMENT AND COMPLICATIONS

Count	Q	A
69	What is the most important intervention and preferred fluid for Pancreatitis?	Fluid Resuscitation; Lactated Ringer's.
70	How is Mild Acute Pancreatitis managed regarding diet?	Resume low-fat solid diet quickly.
71	How is Severe Acute Pancreatitis defined?	Persistent organ failure (>48 hours).
72	What are the components (5) of the BISAP Score?	BUN, Impaired mental, SIRS, Age, Pleural effusion.
73	Why is Enteral Nutrition preferred over parenteral in severe pancreatitis?	Maintains gut barrier integrity.
74	Are Prophylactic Antibiotics recommended for severe acute pancreatitis?	No (No survival benefit).
75	How is Infected Pancreatic Necrosis managed?	Targeted antibiotics; Drainage/debridement.
76	When do Pancreatic Pseudocysts typically form?	4–6 weeks after onset.
77	What is the timeframe for ERCP in ascending cholangitis with pancreatitis?	Within 24–48 hours.
78	What lab finding is characteristic of Pancreatic Ascites fluid?	High amylase level.
79	What localized vascular complication of pancreatitis leads to Gastric Varices?	Splenic Vein Thrombosis.

VII. CHRONIC PANCREATITIS AND SECRETION REGULATION

Count	Q	A
80	What stimulates Secretin release and what is its effect?	Gastric acid; Bicarbonate/Water secretion.
81	What stimulates Cholecystokinin (CCK) release and what is its effect?	Fats/Amino acids; Enzyme-rich secretion.
82	What is the role of Bicarbonate in pancreatic juice?	Neutralizing acid; Optimal enzyme pH.
83	What is the function of Enterokinase?	Converts trypsinogen to active trypsin.
84	How is Negative Feedback of pancreatic enzymes mediated?	Trypsin blunts CCK response.

VIII. COMPARISON CHALLENGE

Count	Q	A
85	Compare Visceral vs. Parietal Pain in terms of quality and localization.	Visceral: Vague/Midline; Parietal: Sharp/Localized.
86	Compare Upper vs. Lower GI Bleed in terms of physical presentation.	Upper: Melena/Hematemesis; Lower: Hematochezia.
87	Compare Cullen's vs. Grey Turner's Sign in terms of location.	Cullen's: Periumbilical; Grey Turner's: Flanks.
88	Compare Lynch Syndrome vs. FAP in terms of polyp count.	Lynch: Few; FAP: Hundreds to thousands.
89	Compare Amylase vs. Lipase in terms of specificity and duration.	Amylase: Short/Less specific; Lipase: Longer/Specific.
90	Compare Moderately Severe vs. Severe Pancreatitis based on organ failure duration.	Mod-Severe: <48 hours; Severe: >48 hours.
91	Compare Secretin vs. CCK in terms of what they stimulate.	Secretin: Bicarbonate (Duct); CCK: Enzymes (Acinar).
92	Compare Interstitial vs. Necrotizing Pancreatitis on CT imaging.	Interstitial: Homogenous; Necrotizing: Lack of enhancement.
93	Compare Type 1 vs. Type 3c Diabetes in terms of pathogenesis.	Type 1: Autoimmune; Type 3c: Exocrine disease.
94	Compare Maldigestion vs. Malabsorption definition.	Maldigestion: Chemical breakdown failure; Malabsorption: Transport failure.
95	Compare Gastric vs. Duodenal Ulcer Pain in relation to meals.	Gastric: Aggravated by meals; Duodenal: Relieved by meals.
96	Compare Lactose Intolerance vs. Celiac Disease in terms of tissue damage.	Lactose: No damage; Celiac: Mucosal injury.
97	Compare Secretory vs. Osmotic Diarrhea in response to fasting.	Secretory: Persists; Osmotic: Improves with fasting.
98	Compare IBD vs. IBS in terms of structural findings.	IBD: Visible damage; IBS: No abnormalities.
99	Compare PRSS1 vs. SPINK1 mutation mechanisms.	PRSS1: Gain-of-function; SPINK1: Loss-of-function.
100	Compare Murphy's vs. McBurney's Point for diagnosis.	Murphy's: Gallbladder; McBurney's: Appendix.
101	Compare Psoas vs. Obturator Sign in terms of maneuver.	Psoas: Hip extension; Obturator: Internal rotation.
102	Compare Enteral vs. Parenteral Nutrition in pancreatitis management.	Enteral: Tube feeding (Preferred); Parenteral: IV.
103	Compare Prokinetics vs. Loperamide clinical use.	Prokinetics: Increase motility; Loperamide: Decrease motility.
104	Compare HNPCC/Lynch vs. Standard CRC screening age.	HNPCC: Much earlier; Standard: Age 45.

notes